Environmental Impacts of One Pot Methamphetamine Clandestine Laboratories - Characterization and Detection of Trace Materials by Green, Matthew Kevin
   ENVIRONMENTAL IMPACTS OF ONE POT  
   METHAMPHETAMINE CLANDESTINE  
   LABORATORIES – CHARACTERIZATION AND  
   DETECTION OF TRACE MATERIALS 
 
   By 
      MATTHEW KEVIN GREEN 
   Bachelor Science in Forensic Biology  
   Ohio Northern University 
   Ada, Ohio 
   2012 
 
   Master of Science in Forensic Science  
   Oklahoma State University 
   Tulsa, Oklahoma 
   2014 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   DOCTOR OF PHILOSOPHY 
   May, 2017  
ii 
 
   ENVIRONMENTAL IMPACTS OF ONE POT  
   METHAMPHETAMINE CLANDESTINE   
   LABORATORIES – CHARACTERIZATION AND  
   DETECTION OF TRACE MATERIALS 
 
 
   Dissertation Approved: 
 
   Jarrad R. Wagner, Ph.D., F-ABFT 
  Dissertation Advisor 
   Lara K. Maxwell, DVM, Ph.D., DACVCP 
 
   David R. Wallace, Ph.D. 
 
   Mark E. Payton, Ph.D. 
.
iii 
Acknowledgements reflect the views of the author and are not endorsed by committee 
members or Oklahoma State University. 
ACKNOWLEDGEMENTS  
 
 
 Any individual mentioned in this section deserves the utmost praise for continued 
support throughout this research project.  First, I would like to thank my dissertation 
advisor, Dr. Jarrad Wagner, for giving me the opportunity and resources to complete this 
doctoral program.  Next, I would like to thank the Center for Veterinary Health Sciences, 
and particularly my dissertation chair, Dr. Lara Maxwell, for providing a model and 
pathway for success.  The academic opportunities both on campus and remotely were 
greatly appreciated.  I would also like to thank the other committee members, Drs. David 
Wallace and Mark Payton, for sharing their enthusiasm and knowledge within the 
classroom and in collaborative efforts towards my research.  I, both personally and 
professionally, have greatly benefited from the leadership and outstanding guidance from 
these graduate committee members. 
  
Recognition must be given to Savannah River National Laboratory, in 
conjunction with the National Institute of Justice, specifically David Pretorius and Dr. 
Frances Scott.  Without the financial support through a grant-funded contract, my 
research and any continuing investigation would not have been possible.  I would also 
like to thank the School of Forensic Sciences at Oklahoma State University, particularly 
the Forensic Toxicology and Trace Laboratory, for providing a platform and all necessary 
equipment to perform the research projects.  An additional sign of gratefulness must be 
given to Austin Ciesielski, who provided continual outstanding effort towards the goals 
of this research. 
  
And lastly, for all of the individuals that helped paved who I am today, shared 
encouraging or consoling words, and/or simply smiled back, I would like to share my 
thanks and gratitude.  Without your presence, either physical or figurative, any and all 
achievements have no value.  Thank you for providing reason and giving me purpose.  
iv 
 
Name: MATTHEW KEVIN GREEN  
 
Date of Degree: MAY, 2017 
  
Title of Study: ENVIRONMENTAL IMPACTS OF ONE POT METHAMPHETAMINE 
CLANDESTINE LABORATORIES – CHARACTERIZATION AND 
DETECTION OF TRACE MATERIALS 
 
Major Field: VETERINARY BIOMEDICAL SCIENCES 
 
Abstract: The One Pot methamphetamine production method has become the primary 
method of choice in clandestine drug laboratories across the United States, due to its 
simplicity and the availability of required materials.  While the method is simple, it also 
generates risk to innocent bystanders within the community from flammability and 
toxicity hazards.  Previous studies have determined the adverse effects of 
methamphetamine consumption, but there has been little research exploring the health 
impact of being in close proximity to methamphetamine manufacturing.  Despite 
investigative efforts, clandestine laboratories may not be discovered for an extended 
period of time, after which, numerous methamphetamine productions will have been 
completed.  As a result, the probability of exposure to toxic substances involved with the 
One Pot method increase significantly.  This study was undertaken to determine and 
quantify the characteristic products and byproducts of the One Pot methamphetamine 
method.  In addition, studies were conducted to determine the feasibility of detection of 
methamphetamine clandestine laboratories through monitoring waste water effluents.  
Methamphetamine was produced by the One Pot method and the methamphetamine 
hydrochloride product was filtered out.  All post-reaction liquids and solids were 
characterized.  In collaboration with local authorities, simulated One Pot 
methamphetamine waste disposal was performed using a representative lift station.  
Waste water samples were collected post-distribution to determine a time course 
detection window and analyzed via solid phase extraction with liquid chromatography-
tandem mass spectrometry.  Methamphetamine, pseudoephedrine, and ephedrine were all 
detectable in the waste water.  Also, an over-reduced product, characteristic of the One 
Pot synthesis, CMP [1-(1',4'-cyclohexadienyl)-2-methyl-aminopropane] was detected.  
As a means to determine the value of CMP as a unique identifier, urine samples that 
previously tested positive for methamphetamine were analyzed, and only one sample 
demonstrated positive results for the primary One Pot byproduct.  This work identifies 
the components produced following One Pot methamphetamine production.  
Additionally, results demonstrate the possibility and potential for analyzing waste water 
to monitor and detect clandestine One Pot methamphetamine laboratories within 
communities. 
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CHAPTER I 
 
 
INTRODUCTION 
Methamphetamine, perhaps the most widely known illicit substance, continues to 
be a drug of major concern.  From its first synthesis in 1893 to becoming a Drug 
Enforcement Administration (DEA) Schedule II compound in 1971, methamphetamine 
has been used in many applications due to the drug’s stimulant properties.  During World 
War II, for example, soldiers were administered methamphetamine to reduce fatigue.1  In 
addition to nonmedical use, doctors in the United States were prescribing 
methamphetamine, and other related amphetamines, to help treat certain conditions like 
hyperactivity and obesity, to name a few.2  In fact, one prescribed form of 
methamphetamine still exists, that being the brand name Desoxyn.  While an argument 
can be made for drug administration in the scenarios listed above, the true problem with 
methamphetamine arises in the illicit and abusive use of the drug.  Around the 1980s, the 
illegal use of methamphetamine began to gain popularity.2  From these scenarios, and 
with consumption levels well above previously reported therapeutic ranges,  
methamphetamine use became a widespread problem. 
As mentioned above, methamphetamine is a powerful stimulant.  According to 
the National Institute on Drug Abuse, it is a synthetic drug that can be used as a white 
powder or crystal glass.  Additionally, this stimulant is typically smoked, but can be 
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administered via other possible routes.3  As with many biology and molecular processes, 
exposure to foreign objects can alter normal function.  Literature has shown that 
methamphetamine causes such alterations with dopamine and its molecular players, 
including dopamine receptor and dopamine transporter.  Methamphetamine can increase 
dopamine release and function in the brain.4  Historically, methamphetamine was used 
for medicinal purposes, but with the strong majority of this drug unavailable through 
legal action, it is more recently abused as an illicit substance.  And instead of 
administering therapeutic levels, unmonitored methamphetamine use has the potential 
and in most cases, likelihood of reaching high or toxic drug concentrations.  Before any 
interaction can take place, methamphetamine, as is the case with other drugs, must first 
enter the neuron.  The dopamine transporter controls the active re-uptake of dopamine 
from the synapse, which is the part of a neuron that allows for signal transfer.5  In 
addition to increasing dopamine release, methamphetamine also blocks re-uptake of 
dopamine, thus cancelling the function of the transporter.  In this sense, the combination 
of extra dopamine release and dopamine not being able to be transferred back into the 
terminal creates an additive-like effect.  The pleasure and reward system associated with 
dopamine is intensified when under the influence of methamphetamine.  This intensity is 
commonly referred to as the euphoria or “high” that users will describe.  The molecular 
characteristics listed above contribute greatly to the continued used and addiction 
commonly associated with methamphetamine. 
Historical and prescription uses for methamphetamine have displayed minor 
prevalence and success, but illicit use has witnessed increasing popularity.  Several 
hypotheses may explain this trend, but one likely cause is the formation of clandestine 
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laboratories.  While the majority of these “laboratories” do not resemble a typical 
academic or research laboratory, they are considered such because they perform a 
chemical reaction, i.e. converting a starting material into methamphetamine.  Clandestine, 
by definition, means hidden or operated in secrecy.  Individuals, either looking to use or 
sell methamphetamine, can manufacture the drug within a residence or other dwelling of 
choice.  Despite the incentive to produce methamphetamine individually, the process and 
its ingredients create a hazardous environment, which has the potential to become 
severely dangerous.  The unsafe conditions are exposed to family, friends, and pets living 
within the immediate area, but also any first responders and law enforcement personnel 
who may enter the scene.  A study conducted in 1996, reviewed the adverse medical 
effects in clandestine laboratory investigators.  Findings from the retrospective study 
indicated that methamphetamine laboratories accounted for 81-97% of all law 
enforcement responses and if health issues were reported, symptoms primarily included 
headache and respiratory, mucous membrane, and skin irritation.6  While safety measures 
within law enforcement communities have likely increased over the past 20 years, 
innocent bystanders within dangerous clandestine environments are unlikely to be 
equipped with the proper personal protective equipment.  An additional note is that the 
law enforcement personnel are only exposed to potential dangers for a short, limited time 
period.  Residents living within, on the other hand, may experience exposure for weeks, 
and possibly months.  Due to the abundant health risks, research needs to be conducted to 
determine the amounts of contamination within typical clandestine laboratories.   
In 2005, VanDyke et al. developed a study within an actual household to examine 
the clandestine scene over a 24-hour period.7  To replicate an actual clandestine scene, 
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methamphetamine was manufactured in one room or region of the household.  On day 1, 
two methamphetamine reactions were produced using a previously common procedure 
called the “Red Phosphorus” method, which will be discussed further in Chapter 2.7  
Although the technique is not the same as the more recent and popular “One Pot” 
method, the study still provides insight about possible contamination levels.  On day 2, 
the researchers started collecting evidence, which included atmosphere and wipe samples.  
Based on the results, methamphetamine can be detected within the atmosphere for at least 
24 hours after production.7  Depending on the frequency of methamphetamine 
manufacturing, anyone dwelling nearby may have a constant exposure, or at the very 
least, consistent exposure to toxic methamphetamine fumes.  The authors noted that the 
airborne methamphetamine particles were rather small and had the ability to be inhaled 
by anyone near the production site.7  Another sample type collect was wipes or swabs.  
As the name suggests, a piece of material can be swiped across a hard surface, furniture, 
piece of clothing, etc. and then extracted to detect the presence of drugs collected on the 
wipe.  Results for this type of sample collection demonstrated positive methamphetamine 
detection in every room of the house, and even on the clothing of the researchers.7  The 
findings from this study confirm the presence of methamphetamine and related chemicals 
throughout the immediate area surrounding a manufacturing reaction.  Additionally, the 
detection of toxic fumes and surface contamination in adjoining or adjacent rooms of the 
house, provided understanding that health risks associated with clandestine laboratories 
can spread to nearby areas.  An important note, as discussed by the authors, is that there 
is high variability amongst methamphetamine laboratories, in terms of production and 
exposure.7  Therefore, any controlled research results must be interpreted individually. 
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Although prior work has been done to help fully understand clandestine 
laboratory contamination potentials, continued research is needed to characterize results 
from more recent methamphetamine manufacturing methods.  As briefly mentioned 
above, the One Pot method has become the primary method of choice for quick and easy 
methamphetamine manufacture.  Expanded details on this specific method will be further 
discussed in Chapter 2.  While research within the literature pertain to older 
manufacturing techniques, very few projects have been conducted to understanding not 
only the potential contamination levels, but also the hazards produced by the One Pot 
method.  Additionally, the health and environmental hazards created during 
methamphetamine manufacturing has produced a demand to proactively locate 
clandestine laboratories within the community.  To achieve this goal, distance monitoring 
appears to be a practical technique to pursue.  One potential pathway to detect the 
presence of clandestine laboratories is following reaction waste disposal.  Disposal routes 
include, but are not limited to, private property, public areas, and the sewer system.  
“There are two significant issues relating to such dumps of materials; they might contain 
valuable evidence as to drug manufacture, and they might be a source of pollution.”8  
Analysis of waste water for target drug compounds has shown continued success, and 
will be explained in Chapter 2.  Therefore, if drug compounds associated with 
methamphetamine, specifically the One Pot manufacturing method, can be detected 
within sewage effluent, determination of the location or general area of clandestine 
laboratories may be possible.   
A signature byproduct of the One Pot method has been identified as 1-(1',4'-
cyclohexadienyl)-2-methyl-aminopropane, commonly referred to as CMP.  Before this 
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study, the amount of byproduct produced in a One Pot method and its potential use as a 
clandestine laboratory identifier had not been documented.  The goals of this study 
include the following: 
1) characterize the One Pot methamphetamine method,  
2) develop waste water analysis methodologies to detect One Pot waste in sewage 
effluent, and 
3) determine the significance of detecting the primary One Pot byproduct, CMP, 
within environmental samples. 
Each goal, as expected, has an associated hypothesis.  Respectively, the hypotheses 
include: 
1) the One Pot methamphetamine method produces signature impurities, within both the 
final product and waste materials, that can uniquely identify the manufacturing 
technique, 
2) One Pot waste products and byproducts are detectable in sewage effluent, and 
3) CMP, following consumption within a One Pot methamphetamine salt, can be 
detected within urine. 
For the first study, as completely explained in Chapter 2, One Pot 
methamphetamine was produced using two solvent types, diethyl ether and camp fuel, as 
the reaction medium.  Reactions were conducted at the Oklahoma State University – 
Forensic Toxicology and Trace Laboratory (OSU-FTTL), and methamphetamine 
products and waste materials were analyzed using liquid chromatography-tandem mass 
spectrometry (LC-MS/MS).  Results establish potential yields found within One Pot 
methamphetamine laboratories, and discover the detectable presence of target compounds 
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within reaction waste.  The second study, discussed in Chapter 3, was achieved by 
creating a simulated One Pot waste disposal experiment.  The One Pot reaction wastes, 
from the two solvent types mentioned above, were deposited into a local waste water 
system, with coordination through local authorities.  Sewage effluent samples were 
collected downstream over time.  Waste water samples were then prepared for 
instrumental analysis through solid phase extraction (SPE).  Results indicate a significant 
increase or spike in One Pot target compound concentrations following a simulated 
disposal.  The findings from this experiment demonstrate the potential to further improve 
and implement waste water analysis as a means to track and locate One Pot clandestine 
laboratories.  And lastly, the third study, as detailed in Chapter 4, was investigated by 
analyzing human urine samples that had previously tested positive for methamphetamine.  
The approach was developed to understand if the primary One Pot byproduct, CMP, was 
detectable in urine post-methamphetamine consumption.  Findings confirm the possibility 
of detection, but further research is needed to completely understand CMP and its 
interaction within the human body. 
Overall, the research conducted within the three following chapters provides both 
previously unknown knowledge and a demand for continued investigation into the One 
Pot methamphetamine method.  For the first time, One Pot methamphetamine product 
and reaction waste yields have been reported.  Although clandestine laboratory yields can 
be highly variable, the results established the primary compounds of interest that would 
be important to monitor in any detection campaign.  Additionally, a waste water analysis 
method was developed and validated to detect the target compounds of the One Pot 
method.  Finally, investigation was performed to begin the process of understanding 
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CMP within human subjects.  Continued efforts and research in all three facets of this 
study, will continue to increase the awareness of the law enforcement and scientific 
communities in regards to the One Pot manufacturing method, with the end goal of being 
able to proactively remove the dangerous clandestine laboratories from the community 
and environment before more harm is done.
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CHAPTER II 
 
 
ONE POT METHAMPHETAMINE CHARACTERIZATION 
2.1 Introduction 
Throughout the decades of methamphetamine manufacturing, there have been 
numerous methodologies to produce the illicit stimulant.  Among these production 
techniques, include more popular methods such as the “Phenyl-2-Propanone”, “Red 
Phosphorus”, and “Birch Reduction” methods, to name a few.  The aforementioned 
methodologies all result in the production of methamphetamine.  However, each method 
utilizes varying ingredients, requires a different step-wise procedure, and produces 
signature byproducts.  Through examination of the ingredients used, waste materials left 
behind, and trace detection of unique identifiers, law enforcement and the scientific 
community have had the ability to determine the method of production.  Not only does 
this knowledge assist in understanding drug manufacturing trends within a certain 
population or region, understanding the production method can assist in tracking down 
the clandestine laboratory and/or the individual(s) producing methamphetamine.  The 
Drug Enforcement Administration (DEA), with the assistance of several research 
projects, created a Methamphetamine Profiling Project (MPP) to track and monitor 
methamphetamine production within the country.9  Byproducts, indicative of the 
manufacturing technique, have been identified by analyzing the final methamphetamine
10 
 
product or salt.  Although the majority of the salt is, in fact, methamphetamine, trace 
impurities can be detected with analytical instrumentation.  Updated and complete 
knowledge of a methamphetamine production method can enhance identification within 
the community, and support research projects designed to improve detection capabilities. 
As of recent, the “One Pot” method has emerged as the production technique of 
choice within clandestine methamphetamine laboratories.  Due to the simplistic 
procedure and easy access to required ingredients, the One Pot method has become a 
widespread problem across the United States.  As shown in Figure 1, the DEA released 
statistics in the 2016 National Threat Assessment regarding methamphetamine 
laboratories.10 
Figure 1. Number of Methamphetamine Laboratories Seized from 2010-2015.  Bar graph obtained from DEA 2016 
National Threat Assessment. 
 
According the bar graph, the number of seized clandestine laboratories have actually 
decreased.  However, two adjoining factors indicate that One Pot methamphetamine is 
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still prevalent throughout the country.  The first is that the number of seizures each year 
does not account for clandestine laboratories left unfound.  The second is that a strong 
majority, 86 percent, of laboratories seized each year had less than two ounces of final 
product present.  Small quantities of methamphetamine, less than 2 ounces, are indicative 
of a One Pot laboratory.  “Generally, these laboratories are small-scale, easy to conceal, 
and produce.”10  However, with all the risks associated with methamphetamine itself, the 
dangers of drug production create the opportunity for additive hazards.  The popularity of 
One Pot laboratories within communities demonstrates a need to fully understand all 
products and byproducts created during the process.  Until this project, little to no 
research has been done to fully characterize the One Pot methamphetamine method. 
 The purpose of this study was to investigate every aspect of the One Pot 
methamphetamine method post-reaction.  Methamphetamine was manufactured in a safe, 
laboratory environment at the Oklahoma State University – Forensic Toxicology and 
Trace Laboratory (OSU-FTTL).  The One Pot method developed by OSU-FTTL was 
adjusted from a One Pot method available through the Internet.  Minor adjustments were 
performed in regards to increasing safety, but did not alter the overall reaction.  
Following One Pot syntheses, all components, including the final product, were analyzed 
using liquid chromatography-tandem mass spectrometry (LC-MS/MS).  
Methamphetamine, pseudoephedrine, ephedrine, and CMP [1-(1',4'-cyclohexadienyl)-2-
methyl-aminopropane], a documented byproduct, were detected and quantified.  
Concentrations and percentages of target compounds present within the products and 
waste materials obtained provide awareness of the One Pot methamphetamine method, 
and insight regarding potential environmental contamination. 
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2.2 Review of the Literature 
 
Methamphetamine in its useable form, typically a salt, will show little to no 
deviation in appearance regardless of the manufacturing method.  Figure 2, below, 
demonstrates examples of the possible pathways.11  As a side note, the goal of this 
section is not to discuss, in detail, all of the pathways illustrated, but review the discovery 
of unique identifiers for each.   
Figure 2. Diagram of Various Routes to Produce Methamphetamine.  Figure obtained from Stojanovska et al. 2013. 
 
While visual observation of the final methamphetamine salt proves unsuccessful, 
laboratory analysis can reveal unique byproducts or impurities within the product that 
indicate the technique or precursors used to produce the drug.  The importance of the 
ability to track the type manufacturing method used is that the information gained can be 
used in a variety of applications, within the law enforcement community for example.  
“Impurity profiling can provide information to help identify relationships between drug 
seizures, drug sources and trafficking routes.”12  Organizations within the United States, 
as well as the rest of the world, have created programs and/or research projects to 
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establish the ability to monitor methamphetamine byproducts.  The following section will 
review literature pertaining to the identification of unique identifiers that link a 
methamphetamine drug sample to its corresponding manufacturing process.  Several 
research projects have explored the impurities of the P2P, Red Phosphorous, and Birch 
Reduction methods.  However, the One Pot method, which has shown continued 
popularity in clandestine laboratories, and potential signature byproducts, has yet to be 
fully investigated. 
As mentioned above, there have been several methamphetamine production 
techniques implored throughout the 20th century.  The first prominent technique will be 
referred to as the “Phenyl-2-Propanone” or P2P method, named after the precursor used 
to produce methamphetamine.  The two major routes of manufacture are termed the 
“Reductive Amination” and “Leuckart” methods.13  While these two specific 
methodologies have differing procedures, they both utilize phenyl-2-propanone as the 
precursor in the reaction.  A 1980s report based on 190 methamphetamine laboratories 
seized by the DEA, established that the P2P method was implored in over 50 percent of 
the cases.14  In a laboratory seizure, identification of the manufacturing method is 
typically not a challenge due to the presence of all the ingredients, and occasionally, a 
signature smell or odor.  For example, a laboratory with precursor, methylamine, 
hydrochloric acid, formic acid, and mercury, as well as distinct cat urine odor, would be 
indicative of the P2P method.15  While knowledge of laboratory specifics can provide 
confirmatory results of the manufacturing technique, the information is not always 
available.  The final product of methamphetamine salt may be the only evidence seized or 
intercepted.  However, trace components within the final product can indicate the method 
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of production.  “As the synthesis proceeds, various impurities are accumulated: reactants, 
byproducts, and intermediates, as well as contaminants rising from within the reagents 
themselves.”16  A demand for identification of production route-specific impurities found 
in methamphetamine final products spurred several research projects.   
As early as 1977, research was being conducted to better understand the P2P 
method, and identify manufacturing impurities.  Kram and Kruegel utilized gas 
chromatography-mass spectrometry (GC-MS) and nuclear magnetic resonance (NMR) 
spectroscopy to identify several impurities of the P2P method, the Leuckart method in 
particular.  The identified trace components included the following compounds: methyl 
benzyl ketone, amphetamine, N,N-dimethylamphetamine, dibenzylketone, ,-
dimethyldiphenethylamine, N-methylformamide, formic acid, methylamine, and N-
formylamphetamine.16  While not all trace components may be present in every sample, 
the knowledge of these possible contaminants within the methamphetamine salt can assist 
future investigations and research.  In 1984, a separate research group continued the 
research above, but solely focused on the N-methylformamide impurity.  Conclusions 
within this study stated that N-methylformamide was readily detected via GC-MS in 
methamphetamine samples from multiple P2P reactions.17  An important note resulting 
from this project is that the authors experienced variable amounts of impurities between 
product samples.  While the P2P reactions were performed in a controlled setting, the 
differing levels of impurities can be predicted to be present within the clandestine 
community as well.  In contrast to P2P methamphetamine produced “in house”, Dyrit and 
Dumlao conducted a study of impurities within seized methamphetamine using GC-MS 
and GC with a flame ionization detector (GC-FID).  The research group reported four 
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previously unidentified impurities, those being p-bromotoluene, N-benzyl amphetamine, 
N-ethyl amphetamine, and N-ethyl methamphetamine.18  Despite the methamphetamine 
samples coming from an unknown origin or manufacturing technique, the research group 
was also able to detect trace amounts of P2P, N,N-dimethylamphetamine, and N-
formylamphetamine, which has been identified or is similar to contaminants already 
identified as originating from a P2P reaction. 
A more recent study confirmed the aforementioned work, and provided a more 
decisive conclusion with regards to specific identifiers of the P2P manufacturing process.  
According to Kunalan et al., three compounds were likely to be unique identifiers of this 
manufacturing technique: ,-dimethyldiphenethylamine, N-,-
trimethyldiphenethylamine, and 1-phenyl-2-propanol.19  The research group utilized GC-
MS to obtain and compare the known methamphetamine impurities based on two varying 
P2P production methods.  Another review pertaining to the P2P method concluded that 
other unique identifiers of this production type included amphetamine, 1,3-diphenyl-2-
methaminopropane, and N-cyanomethyl-N-methyl-1-phenyl-2-propylamine.11  While any 
of the compounds listed above may not be commonly found substances, the mere 
identification for future monitoring provided desired assistance for the detection and 
tracking of this type of manufactured methamphetamine.  
Due to the popularity and widespread use of the P2P method, the DEA designated 
phenyl-2-propanone as a Schedule II compound in 1980.  While some manufacturers 
sought to avoid this restriction by creating phenyl-2-propanone themselves, the majority 
of individuals and/or groups switched methodologies to using ephedrine and/or 
pseudoephedrine as the starting material.15  As a reading note, any use of the word 
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“pseudoephedrine” implies that of pseudoephedrine and/or ephedrine, thus combining the 
two compounds into one name for simplicity.  However, both compound names will be 
mentioned if necessary for listings in methodology, results, interpretations, etc.  
Incentives to switch to using pseudoephedrine as the methamphetamine precursor 
obviously included elusion from law enforcement surveillance, but also, elimination of 
precursor production steps.  Pseudoephedrine, a common nasal decongestant, is available 
for purchase at most pharmacy stores.  In fact, the amount an individual could purchase 
was seemingly unlimited until the mid 2000s.  The Combat Methamphetamine Epidemic 
Act of 2005 was enacted, which limited the amount of pseudoephedrine an individual 
could purchase in a specific timeframe.20  Therefore, from about 1980 through 2005, 
clandestine laboratories individuals, once learning of the pseudoephedrine pathway to 
methamphetamine, had unregulated access to the starting material.  The readily available 
over-the-counter medication gave rise to the increasing number of pseudoephedrine-
based laboratories throughout the country, as introduced in the previous section.  Shortly 
following the implemented monitoring and limitations of pseudoephedrine purchases in 
2005, clandestine laboratory seizures did experience a drop, but an obtainment method 
called “smurfing” continued methamphetamine manufacturing popularity.21  Essentially, 
a clandestine laboratory can hire or persuade outside individuals to purchase the 
maximum allowable amount of pseudoephedrine and provide it to the laboratory.  Once 
the limited timeframe has passed, the same individual(s) can return the store to buy 
another set of the maximum allowable amount and the cycle continues.  Regardless of the 
various techniques to obtain the starting material, pseudoephedrine was being used to 
produce methamphetamine through a variety of different routes.  
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 While the P2P method has a couple general routes of synthesis, the 
pseudoephedrine-based method contains many variations.  Returning to Figure 2, the 
generally accepted names include the Nagai, Moscow, Hypo, and Birch Reduction 
methods.11  A more recent addition to this list is the One Pot method which has also been 
termed the “Shake and Bake” method.  However, for the purposes of this review, the One 
Pot method will be discussed separately in a following segment.  Despite the many 
names, the various techniques can be sectioned into groups that will be referred to in this 
chapter as “Red Phosphorus” and “Birch Reduction” methods.  Similar to the P2P 
method, several research projects have been conducted to identify the impurities or 
byproducts within the product methamphetamine salts of each of these two 
manufacturing groups. 
 For the Red Phosphorus method, named after one of the main ingredients, red 
phosphorus along with hydriodic acid or iodine are used to convert pseudoephedrine into 
methamphetamine.  Around the 1990s, this manufacturing method was the most 
commonly used in the United States, in part, because it produced a more potent form of 
methamphetamine than the P2P method.22  Methamphetamine has two isomers, d- and l-
methamphetamine.  The Red Phosphorus method produces strictly d-methamphetamine, 
rather than a mixture of the two isomers.22  Although the P2P method product can be 
further manipulated to isolate the more potent form, d-methamphetamine, the extra time 
and effort does not make the endeavor desirable.  Despite a more potent 
methamphetamine produced via the Red Phosphorus method, byproducts within the final 
product still exist. 
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One researcher reported that two impurities following the Red Phosphorus 
method are phenyl-2-propanone and naphthalene.22  This result is potentially a very 
crucial finding, in that, the presence of phenyl-2-propanone within a methamphetamine 
salt sample, could indicate both the utilization of a P2P or Red Phosphorus method.  The 
author also mentioned that pseudoephedrine was detectable if the reaction did not reach 
completion.  In 1995, Windahl continued investigation into the Red Phosphorus method, 
and reviewed and confirmed the presence of previously identified impurities.  The list of 
identifiers included phenyl-2-propanone, cis and trans-1,2-dimethyl-3-phenylaziridine, 1-
benzyl-3-methylnapthlaene, and 1,3-dimethyl-2-phenylnapthalene.23  The majority of 
these findings were conducted on a GC-MS system, and some groups utilized NMR as 
well.  However, the contributors of this review, were able to discover two previously 
unidentified byproducts.  These specific impurities include N-methyl-N-(-
methylphenethyl)amino-1-phenyl-2-propanone and a cis-cinnamoyl derivative of 
methamphetamine.23  As stated previously, the impurities identified may be uncommon 
and irregular, but in attribution to the research above, identification via GC-MS database 
can help identify the methamphetamine manufacturing route.  
A more recent study, conducted in 2006, further investigated the impurities of the 
Red Phosphorus method.  Lee et al. discovered previously identified byproducts, such as 
phenyl-2-propanone, but also found N-formylmethamphetamine and N-
acetylmethamphetamine.24  These two compounds had only been identified as impurities 
of the P2P manufacturing method.  The interpretations from this project confirm the 
importance to consider the possibility of impurities that are not definitively 
manufacturing route-specific.  In 2007, a group analyzed the Red Phosphorus method 
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during their efforts to compare the various alkaloids of Ephedra, the plant from which 
pseudoephedrine and ephedrine naturally originate.  The reactions pertaining to the Red 
Phosphorus method produced the following intermediates and byproducts according to 
GC-MS: cis- and trans-1,2-dimethyl-3-phenyl-aziridine, 1-phenyl-2-propanone, 1,3-
dimethyl-2-phenylnaphthalene, and 1-benzyl-3-methylnaphthalene.25  These findings 
confirm the presence of unique identifiers of the Red Phosphorus method to manufacture 
methamphetamine. 
As mentioned above, one of the key ingredients to the Red Phosphorus method is 
iodine.  However, the Comprehensive Methamphetamine Control Act in 1996 placed 
iodine on a list with compounds closely associated with methamphetamine production.26  
Increased surveillance and consequential reduction of iodine availability, forced 
clandestine laboratories to seek out another technique to produce methamphetamine.  The 
second general manufacturing method utilizing pseudoephedrine is called the Birch 
Reduction method.  Typically, this method utilizes the reaction of lithium and liquid 
ammonia, in combination with the pseudoephedrine precursor.27  With increased use of 
this methodology, post-1996, another demand was created for identification of the Birch 
Reduction byproducts and impurities.  In 1999, Bremer and Woolery produced a study 
focused on a Birch Reduction byproduct that had been tentatively identified.  The 
authors, with assistance from Dal Cason28, confirmed the identity of 1-(1’,4’-
cyclohexadienyl)-2-methylaminopropane, referred to as CMP, in the methamphetamine 
product of Birch Reduction reactions.29  Unlike the previous manufacturing methods with 
many potential impurities, the focal byproduct of the Birch Reduction is CMP.  
According to the aforementioned study, “It is not likely that an operator would achieve a 
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yield of 80% or higher in a typical clandestine laboratory.” 29  The authors continued to 
explain that a typical yield could be as low as 15-30% due to large amounts of CMP 
being produced when performing the Birch Reduction method.  Following this study, the 
actual structure of CMP was only tentatively predicted in an anonymous publication.30 
In 2005, a research group sought to confirm the structural identity of CMP.  
Person et al. determined the chemical structure utilizing GC-MS and NMR.27  The 
structure of CMP is shown on the far right in Figure 3, below. 
Figure 3. Reaction schematic of the production of CMP.  Figure obtained from Person et al. 2005. 
 
While confirming the structure previously hypothesized, this work increased the ability to 
detect CMP on multiple analytical platforms.  In 2007, Barker and Antia, in their study 
introduced above, also identified CMP as a route-specific indicator of the Birch 
Reduction method.25  The mass spectra of CMP from the study’s findings is shown in 
Figure 4. 
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Figure 4. Mass Spectra of CMP. Figure obtained from Barker and Anita, 2007. 
 
The ability to identify CMP based on comparison with GC-MS database profile greatly 
assisted the identification of methamphetamine being produced via Birch Reduction 
method. 
 Following these research projects, the unique identifiers for the Birch Reduction 
method had been primarily narrowed down to one compound, CMP.  However, in 2012, a 
more comprehensive study was conducted to identify other byproducts of this 
methamphetamine production method.  Kunalan et al. reported a finding of a previously 
undocumented impurity designated as “Unknown 3.”31  While the identity of this 
compound could not be determined, the results demonstrated the potential for a second 
unique identifier of the Birch Reduction method.  In regards to CMP, the research group 
above successfully detected the known byproduct, but only when a pseudoephedrine salt 
was used as the starting material.  If pseudoephedrine was used in freebase form, CMP 
was not detectable in the final product.31  Although the findings of this specific study 
provided another compound to monitor when investigating a methamphetamine sample, 
they also provided an alert that the absence of CMP may not eliminate the Birch 
Reduction method as the manufacturing technique.  In support of this claim, the DEA 
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performed a study about a method to isolate methamphetamine from any CMP impurity.  
Results demonstrated that treating the Birch Reduction method product salt with 
potassium permanganate and an aqueous base would result in sufficient separation of the 
methamphetamine and CMP.32  Although the research was conducted to help create a 
cleaner sample for analysis, the methodologies could be implored in a clandestine setting 
as well to provide a more potent methamphetamine product.  Consequently, this could 
eliminate CMP from being detected in seized methamphetamine from a Birch Reduction 
method.  
 In continuing the trend of clandestine methamphetamine laboratories switching 
manufacturing methodologies following legislative action, the One Pot method became 
increasingly common.  “Newer methods of manufacturing appear as restrictions are 
placed on common manufacturing ingredients.”33  The previous statement has been true 
for the products such as phenyl-2-propanone, iodine, and pseudoephedrine.  The Combat 
Methamphetamine Epidemic Act of 2005, spurred the switch from the Birch Reduction 
method, to a simpler, modified version, being the One Pot method.  A limit was set in 
regards to the amount of pseudoephedrine that could be purchased.  With many of the 
Birch Reduction method procedures utilizing at least 30 grams of pseudoephedrine, 
clandestine laboratories began performing smaller quantity reactions, thus beginning the 
rise in the One Pot method popularity.34 
The One Pot method is a modified Birch Reduction reaction.  Essentially, 
ammonia, a key ingredient in the Birch Reduction method, is generated within the 
reaction of a One Pot.  From there, the generated ammonia reacts with lithium and, in the 
same fashion as the Birch Reduction method, converts pseudoephedrine into 
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methamphetamine.  A desirable characteristic of the One Pot method is that a smaller 
quantity of precursor material is required.  The popularity of this manufacturing 
methodology is proven based on the DEA statistics provided in the previous section.  
According to 2015 statistics, 86% of seized laboratories within the United States had less 
than 2 ounces of methamphetamine.10  To reiterate, small quantities of product within a 
clandestine environment are indicative of a One Pot laboratory.  Due to the widespread 
use of the One Pot method, a couple research projects have been conducted to better 
understand the production yield.  In 2006, Heegel et al. performed One Pot reactions with 
several sources of pseudoephedrine.  Results indicated that many forms of 
pseudoephedrine can successfully be converted to methamphetamine, and without pre-
extraction, unlike the Birch Reduction method.33  An important note is that the quality of 
methamphetamine varied among sources of starting material, which suggests clandestine 
samples may exhibit similar variability.  CMP, one of the signature byproducts of the 
Birch Reduction method, was detected in some of the One Pot reaction products.  
However, the GC-MS results from this study were only semi-quantitative.  Since the One 
Pot method is a mere adjustment and down-scale of the Birch Reduction method, it is 
unsurprising to find the same byproduct.  
A more recent project, performed in 2016 in conjunction with this chapter’s study, 
investigated the impurities found within the One Pot method via GC-MS.  According to 
results, three major byproducts were detected following One Pot syntheses: CMP, 1,2-
dimethyl-3-phenylaziridine, and an unknown compound.35  The first two compounds 
listed have been previously identified in the literature for the Birch Reduction and Red 
Phosphorus methods, respectively.  The unknown compound, found to be structurally 
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similar to pseudoephedrine, produced results comparable to that of impurity of Unknown 
3 from the Kunalan et al. in 2012.35  The results from this study confirm the presence 
CMP within One Pot reactions.  On the other hand, the quantitative amounts of CMP 
produced in a One Pot reaction have yet to be explored.   
In summary, the majority of methamphetamine manufacturing routes have been 
studied analytically.  Impurities in the methamphetamine salts have been investigated as a 
means to provide identifiable information about the production method.  While some 
impurities carry over, or are shared, amongst various manufacturing techniques, the 
ability to detect the unique byproducts can assist in several ways.  Windhal et al. 
describes the avenues as such, “(i) it can reveal information on the synthetic methods 
used to the produce the drug, (ii) it may link samples to a common source dealer or illicit 
laboratory, (iii) their identification is essential so that they do not interfere with the 
analytical techniques used for drug analysis and (iv) the toxicity of these impurities may 
have potential harmful effects on methamphetamine users.”23  In continuation of the 
fourth comment, the impurities can also affect individuals in close proximity to 
clandestine production of methamphetamine.  Due to the lack of literature regarding the 
quantities of One Pot byproducts, CMP in particular, the current study was conducted to 
better understand and provide an example of clandestine methamphetamine yield using 
this method.  In addition, all waste products of the One Pot reaction were analyzed and 
quantitated for the target compounds.  Again, the overall goal was to determine the extent 
of byproduct formation and provide interpretation into the amount of possible 
contamination of innocent bystanders and the environment. 
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2.3 Methodology 
To create One Pot methamphetamine and associated waste materials, a 
laboratory-safe production method was performed at OSU-FTTL.  All reactions took 
place within glass reaction vessels rated for 100 pounds per square inch (psi), placed into 
a laboratory fume hood with overpressure relief valves set to depressurize the cook at 90 
psi.  The ingredients procured for the OSU-FTTL proprietary One Pot method include an 
organic solvent, ammonium nitrate, sodium hydroxide, lithium, water, a mixture of 
pseudoephedrine-HCl and ephedrine-HCl, and hydrochloric acid.  For the reaction 
solvent, ether (diethyl ether) and camp fuel (light petroleum distillate) were used in side-
by-side syntheses as shown in Figure 5.  
 
Figure 5. OSU-FTTL One Pot Reaction Setup.  The side-by-side reactions had identical setups, with the exception of 
solvent type. 
Ammonium nitrate was obtained from instant cold compress packs 
(GoGoods.com, Inc., Columbia, MD).  The camp fuel (Light Petroleum Distillate, CAS 
Number 68410-97-9) was obtained from a local hardware store as Coleman® Camp Fuel 
(Model: 5103B253 Coleman®, Wichita KS).  Ground pseudoephedrine/ephedrine tablets 
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were obtained from a government source.  Sodium hydroxide beads, hydrochloric acid 
(37%), and ACS grade diethyl ether (CAS Number 60-29-7) were purchased from VWR 
Analytical (VWR, Sugar Land, TX).  Lithium ribbon and 99+% hydrogen chloride (HCl) 
gas were purchased from Sigma (Sigma-Aldrich Corp, St. Louis, MO). 
For each synthesis, one gram of ground pseudoephedrine-HCl/ephedrine-HCl 
tablets was added to 250 milliliters of solvent, along with a proprietary ratio of water, 
ammonium nitrate, sodium hydroxide, and lithium ribbon pieces.  All ingredients were 
added to a 400-milliliter pressurized, glass reaction flask, thus initiating the start of the 
One Pot reaction.  An off-gassing apparatus, consisting of valve tubing rated for 150 psi, 
was inserted into the lid of the reaction vessel and included a pressure gauge (SSI 
Technology, Inc., Janesville, WI), an emergency pressure release valve set for 90 psi, and 
a manual valve.  Valve tubing coming from the manual valve was inserted into a 
receptacle filled with water.  The off-gassing apparatus setup is shown in Figure 6, 
below.  Immediately following the start of the reaction, the manual valve was left open to 
the fume hood atmosphere.  After 30 seconds, the manual valve was closed, sealing the 
system for two hours. 
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Figure 6. Off-gassing apparatus used during the One Pot methamphetamine syntheses.  From left to right, the setup 
consisted of a digital pressure gauge, an emergency pressure release valve, and a manual valve. 
Post-reaction, the head space overpressure was slowly released into a receptacle 
filled with water via slight opening of the manual valve closed during the reaction.  Once 
the reaction vessel headspace was fully opened to atmosphere and depressurized, the off-
gassing apparatus was removed, the round-bottom flask lid was unscrewed and removed.  
Lithium was removed from the reaction vessel via forceps and placed into a safe disposal 
or sampling container.  The vessel lid was loosely placed on top of the reaction vessel to 
allow overnight ventilation.  Following the allotted time period, the solvent within the 
reaction vessel was filtered using coffee filters (Farmer Bros Co., Ft. Worth, TX) that had 
been pre-moistened with un-reacted solvent of the respective synthesis.  After filtration, 
the coffee filter was dunked into water to react any trace lithium present.  The solvent 
filtered, deemed “pre-salt” solvent, was poured into a separate, clean bottle.  The 
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remaining solid waste, or sludge, at the bottom of the reaction vessel was dissolved in 
250 mL of water, poured into a separate, clean bottle, and stored for subsequent analysis.  
After collection of the sludge, the pre-salt solvent was purged with hydrogen chloride gas 
from a lecture bottle to convert methamphetamine, any remaining precursor, as well as 
formed byproducts, into hydrochloride salts.  An example of a product salt can be seen in 
Figure 7.  Once precipitation visually ceased, the product salt was recovered with another 
coffee filter, dried and weighed.  The remaining solvent was poured into a separate, clean 
bottle and labeled “post-salt solvent.” 
 
Figure 7. Product Salt. An example of a product salt sample from a One Pot synthesis. 
Six identical reactions were performed, differing only in selection of solvent:  
three syntheses used laboratory-grade diethyl ether and three used camp fuel.  On each 
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synthesis day, an ether reaction was performed alongside a camp fuel reaction to help 
reduce variability between the two cooks.  Diethyl ether syntheses are designated E1, E2 
and E3, and camp fuel syntheses are designated C1, C2 and C3.  All chemicals were 
weighed prior to reaction to a measured precision of less than 0.1 g difference per 
weighed ingredient between the two reaction types.  Following the 2-hour reaction 
explained above, the lithium pieces from the first synthesis of each solvent type, E1 and 
C1, were removed from the reaction vessel, dissolved in 100 mL of deionized water, and 
saved for potential future analysis.  For the remaining reactions, E2-E3 and C2-C3, the 
lithium was removed and quickly immersed into mineral oil for safe disposal.  Sludge, 
post-salt solvent, and product salt samples were collected for analysis in the manner 
described in the previous subsection.  Following a dilution of every sample to eliminate 
instrument saturation, all characterizations samples were placed into injection vials for 
LC-MS/MS analysis. 
Shimadzu UFLC pumps paired with an Applied Biosystems 4000 Q Trap MS/MS 
was used for the LC-MS/MS analysis, shown in Figure 8.  
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Figure 8. LC-MS/MS Instrumentation Setup at OSU-FTTL.  Shimadzu UFLC pumps on the left, and Applied 
Biosystems 4000 Q Trap MS/MS on the right. 
For liquid chromatography, separation was achieved with a Restek Raptor Biphenyl 2.7 
µm column (50 x 2.1 mm) with a Restek Raptor Biphenyl 2.7µm guard cartridge (5 x 3.0 
mm) (Restek Corporation, Bellefonte, PA).  Mobile Phase A consisted of 2mM 
ammonium formate and 0.1% formic acid in LC-MS grade water, while Mobile Phase B 
consisted of 2mM ammonium formate and 0.1% formic acid in LC-MS grade methanol.  
Ammonium formate was purchased from Alfa Aesar (Alfa Aesar, Ward Hill, MA).  
Formic Acid was purchased from EDM (EDM Millipore Corp, Billerica, MA).  Methanol 
was purchased from JT Baker (Avantor Performance Materials Inc., Center Valley, PA).  
Nanopure water was obtained using a Barnstead Nanopure Diamond laboratory water 
system (Thermo Scientific, Waltham, MA).  The LC method had a total flow rate of 
0.700 ml/min.  Mobile Phase B concentration was held at 7.2% for 3.5 minutes, increased 
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to 35% for 1 minute, lowered to 7.2% for 0.25 minutes, increased to 100% for 0.5 
minutes, and then lowered to 7.2% for 1.75 minutes, for a total run time of 7 minutes.  
All changes in mobile phase B concentrations were set to immediately occur and end 
with no ramp.  Injections were set at 20 µL and the oven temperature was set to 30 oC. 
For mass spectrometry, Table 1, below, shows the ion transitions and LC-MS/MS 
instrument parameters for the compounds of interest.  Amphetamine, Amphetamine-d6, 
Methamphetamine, Methamphetamine-d5, 1S,2S(+)-Pseudoephedrine, and 1S,2R(+)-
Ephedrine-HCl standards were all purchased at a concentration of 1 mg/mL from 
Cerilliant (Cerilliant Corp, Round Rock, TX).  Pseudoephedrine-d3 HCl and 1S,2R(+)-
Ephedrine-d3 HCl standards were also bought from Cerilliant at a concentration of 100 
µg/mL.  One gram of CMP-HCl standard was purchased from Cayman (Cayman 
Chemical, Ann Arbor, MI).  For simplicity, the naming of all analytes will be as follows: 
methamphetamine, pseudoephedrine, ephedrine, amphetamine, and CMP.  Additionally, 
there are four deuterated internal standards, methamphetamine-d5, pseudoephedrine-d3, 
ephedrine-d3, and amphetamine-d6. 
Table 1. Mass Spectrometry Parameters.  Target analytes Methamphetamine, Pseudoephedrine, Ephedrine, 
Amphetamine, and CMP were identified using two mass ion fragments each.  Internal standards include 
Methamphetamine-d5, Pseudoephedrine-d3, Ephedrine-d3, and Amphetamine-d6. 
Compound 
Q1 Mass 
(Da) 
Q3 Mass 
(Da) 
DP 
(volts) 
CE 
(volts) 
CXP 
(volts) 
Methamphetamine 150.100 91.000 56.000 25.000 14.000 
  150.100 119.000 56.000 15.000 4.000 
Methamphetamine-d5 155.000 91.100 60.000 20.000 4.000 
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Trueness of the compound identity was confirmed through comparing the areas of the 
two MRM transitions, resulting in an identification or ID ratio, also known as an MRM 
ratio.  Every Q1 Mass and Q3 Mass pairing generated a chromatographic peak.  MRM 
ratios for each compound, with the exception of internal standards, were calculated by 
dividing the peak area of the second pairing by the peak area of the first pairing.  To build 
an acceptable ID ratio range, the ratios observed for every calibrator were averaged.  For 
results to be accepted, the ID ratio must be within 30% of the ID ratio average using two 
significant figures for the percentage value. 
Pseudoephedrine 166.180 148.024 41.000 15.000 6.000 
  166.180 90.961 41.000 43.000 12.000 
Pseudoephedrine-d3 169.200 151.040 26.000 21.000 26.000 
Ephedrine 166.108 117.085 41.000 27.000 18.000 
  166.108 114.796 41.000 35.000 18.000 
Ephedrine-d3 168.980 116.999 31.000 29.000 6.000 
Amphetamine 136.200 119.000 36.000 13.000 18.000 
  136.200 91.000 36.000 25.000 14.000 
Amphetamine-d6 142.100 125.100 41.000 13.000 6.000 
CMP 152.163 79.114 41.000 27.000 12.000 
  152.163 77.071 41.000 45.000 0.000 
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 To generate a quantitative value for each compound, a calibration curve 
containing all target compounds was utilized.  The linear range for all non-internal 
standard compounds in the LC-MS/MS method mentioned above contained the following 
calibrator points: 100, 50, 25, 5, 1, and 0.5 ng/mL of each drug compound.  To calculate 
the concentration of all calibrators, quality controls, and research samples, MultiQuant 
software (SCIEX, Foster City, CA) was utilized, which is specifically designed for LC-
MS/MS result analysis.  All other values and statistical comparisons were obtained by 
utilizing Microsoft Excel (Microsoft Corporation, Redmond, WA). 
2.4 Findings 
 LC-MS/MS analysis was performed using Shimadzu UFLC pumps paired with an 
Applied Biosystems 4000 Q Trap MS/MS.  As mentioned in the Methodology section 
above, the sample types collected from the characterization syntheses included product 
salt, sludge, and post-salt solvent samples. 
For product salt samples, methamphetamine, CMP, pseudoephedrine, and 
ephedrine were all detected.  The LC-MS/MS quantification results are shown in Table 2.  
All values are listed in ng/mL and an asterisk designation refers to a result that met 
identification criteria, but did not quantitate above the limit of quantitation (LOQ). 
Table 2. LC-MS/MS quantification results for the product salts.  All concentrations given in ng/mL.  Concentration 
below the LOQ of 0.5 ng/mL are designated with an asterisk. 
Compound E1 E2 E3 C1 C2 C3 
Methamphetamine 21.8 56.3 35.9 23.1 35.6 25.8 
CMP 1.62 2.19 2.28 0.22* 0.24* 0.16* 
Pseudoephedrine 8.60 8.39 12.0 14.7 10.4 14.2 
Ephedrine 36.9 44.2 52.1 59.8 33.4 49.7 
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The percentage of methamphetamine, CMP, pseudoephedrine, and ephedrine found in the 
product salts were calculated to compare the amounts of product and impurities present in 
each product salt; these percentages are summarized in Table 3. 
Table 3. Percent of methamphetamine, CMP, pseudoephedrine, and ephedrine found in each product salt with LC-
MS/MS.  All values listed are percentages based on 100% for complete drug composition within the sludge sample. 
Compound E1 E2 E3 C1 C2 C3 
Methamphetamine 31.6 50.7 35.1 23.6 44.7 28.7 
CMP 2.35 1.97 2.23 0.23 0.30 0.18 
Pseudoephedrine 12.5 7.56 11.7 15.0 13.1 15.8 
Ephedrine 53.6 39.8 50.9 61.2 41.9 55.3 
Statistical analysis of a two-population t-test, comparing average compound 
concentrations in product salt samples of ether and camp fuel One Pot syntheses, 
produced the corresponding results listed in Table 4.  Based on the p-values, the mean 
concentrations of all drug compounds between ether and camp fuel syntheses are not 
statistically different.  CMP was not statistically compared because the average value of 
camp fuel samples was below LOQ. 
Table 4. Statistical Comparison of Ether and Camp Fuel Product Salt Samples.  A two-population t-test was performed 
to compare the mean average concentration of ether and camp fuel for methamphetamine, psuedoephedrine, and 
ephedrine.  A generated p-value less than 0.05 translates to a statistical difference between the two solvent types.  A p-
value less than 0.01 or less than 0.001, indicate a high statistical difference or extreme statistical difference, 
respectively. 
Product Salts (ng/mL) Ether Camp Fuel p-value 
Methamphetamine 37.96 28.16 0.412   
Pseudoephedrine 9.66 13.08 0.126   
Ephedrine 44.39 47.65 0.732   
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p –values used to calculate the mean met acceptance criteria, but the concentrations 
quantitated below the LOQ set at 0.5 ng/mL.  
*p-values<0.05 signifying a statistical difference between the concentrations observed in the 
ether cooks and the camp fuel cooks. 
**p-values<0.01 signifying a high statistical difference between the concentrations observed 
in the ether cooks and the camp fuel cooks. 
***p-values<0.001 signifying an extreme statistical difference between the concentrations 
observed in the ether cooks and the camp fuel cooks. 
For sludge samples, the quantification results are displayed in Table 5.  All values 
listed are in mg/mL.  Methamphetamine, pseudoephedrine, and ephedrine were observed 
in all samples and quantitated.  CMP, however, was only detected in the sludge from the 
diethyl ether One Pot syntheses. 
Table 5. LC-MS/MS quantification results for sludge samples.  All concentrations given in mg/mL. 
Compound E1 E2 E3 C1 C2 C3 
Methamphetamine 4.46 8.78 2.66 0.31 1.14 0.78 
CMP 0.31 0.35 0.19 - - - 
Pseudoephedrine 0.94 0.57 0.82 0.39 0.45 0.61 
Ephedrine 4.30 2.46 3.05 1.86 2.15 3.24 
The percentages of methamphetamine, CMP, pseudoephedrine, and ephedrine found in 
the sludge were calculated to compare the amounts of product and precursor left behind 
from the methamphetamine syntheses.  These percentages are summarized in Table 6.  
Percentages from the LC-MS/MS data were calculated by using the determined 
concentrations of each chemical. 
Table 6. Percent of methamphetamine, CMP, pseudoephedrine, and ephedrine found in each sludge sample with LC-
MS/MS.  All values listed are percentages based on 100% for complete drug composition within the sludge sample. 
Compound E1 E2 E3 C1 C2 C3 
Methamphetamine 44.6 72.3 39.6 12.0 30.5 16.9 
CMP 3.07 2.89 2.8 0.00 0.00 0.00 
Pseudoephedrine 9.35 4.66 12.2 15.3 12.2 13.1 
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Ephedrine 43.0 20.2 45.4 72.7 57.3 70.0 
Statistical analysis of a two-population t-test, comparing average compound 
concentrations in sludge samples for ether and camp fuel One Pot syntheses, produced 
the corresponding results listed in Table 7.  Based on the p-values, the mean 
concentrations of all drug compounds between ether and camp fuel syntheses are not 
statistically different.  CMP was not statistically compared because this compound was 
not detected in the camp fuel samples. 
Table 7. Statistical Comparison of Ether and Camp Fuel Sludge Samples.  A two-population t-test was performed to 
compare the mean average concentration of ether and camp fuel for methamphetamine, psuedoephedrine, and 
ephedrine.  A generated p-value less than 0.05 translates to a statistical difference between the two solvent types.  A p-
value less than 0.01 or less than 0.001, indicate a high statistical difference or extreme statistical difference, 
respectively. 
Sludge (mg/mL) Ether Camp Fuel p-value 
Methamphetamine 5.30 0.74 0.068 
Pseudoephedrine 0.77 0.48 0.084 
Ephedrine 3.27 2.41 0.283 
*p-values<0.05 signifying a statistical difference between the concentrations observed in the 
ether cooks and the camp fuel cooks. 
**p-values<0.01 signifying a high statistical difference between the concentrations observed 
in the ether cooks and the camp fuel cooks. 
***p-values<0.001 signifying an extreme statistical difference between the concentrations 
observed in the ether cooks and the camp fuel cooks. 
For post-salt solvent samples, the quantification results are displayed in Table 8.  
All values listed are in ng/mL.  Methamphetamine, pseudoephedrine, and ephedrine were 
found and quantitated.  CMP, however, was only detected in the post-salt solvent from 
the diethyl ether One Pot syntheses. 
Table 8. LC-MS/MS quantification results for post-salt solvents.  All concentrations given in ng/mL. 
Compound E1 E2 E3 C1 C2 C3 
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Methamphetamine 60,600 50,600 29,700 630 20.0 808 
CMP 5,800 4,030 3,420 - - - 
Pseudoephedrine 7,370 8,630 2,900 185 6.00 424 
Ephedrine 5,530 5,070 4,090 327 5.00 272 
The percentage of methamphetamine, CMP, pseudoephedrine, and ephedrine found in the 
post-salt solvents were calculated to compare the amounts of product and impurities 
present in each post-salt solvent; these percentages are summarized in Table 9.   
Table 9. Percent of methamphetamine, CMP, pseudoephedrine, and ephedrine found in each post-salt solvent with LC-
MS/MS. 
Compound E1 E2 E3 C1 C2 C3 
Methamphetamine 76.4 74.1 74.0 55.2 64.5 53.7 
CMP 7.31 5.9 8.54 0.00 0.00 0.00 
Pseudoephedrine 9.30 12.6 7.23 16.2 19.8 28.2 
Ephedrine 6.98 7.41 10.2 28.7 15.7 18.1 
Statistical analysis of a two-population t-test, comparing average compound 
concentrations in post-salt solvent samples for ether and camp fuel One Pot syntheses, 
produced the corresponding results listed in Table 10.  Based on the p-values, the mean 
concentrations of all drug compounds between ether and camp fuel syntheses are 
statistically different.  CMP was not statistically compared because this compound was 
not detected in the camp fuel samples. 
Table 10. Statistical Comparison of Ether and Camp Fuel Post-Salt Solvent Samples.  A two-population t-test was 
performed to compare the mean average concentration of ether and camp fuel for methamphetamine, psuedoephedrine, 
and ephedrine.  A generated p-value less than 0.05 translates to a statistical difference between the two solvent types.  
A p-value less than 0.01 or less than 0.001, indicate a high statistical difference or extreme statistical difference, 
respectively 
Post-Salt Solvent (ng/mL) Ether Camp Fuel p-value 
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Methamphetamine 46957 486 0.007**   
Pseudoephedrine 6297 205 0.025*     
Ephedrine 4896 201 0.000*** 
*p-values<0.05 signifying a statistical difference between the concentrations observed in the 
ether cooks and the camp fuel cooks. 
**p-values<0.01 signifying a high statistical difference between the concentrations observed in 
the ether cooks and the camp fuel cooks. 
***p-values<0.001 signifying an extreme statistical difference between the concentrations 
observed in the ether cooks and the camp fuel cooks. 
2.5 Discussion 
Following One Pot reactions, LC-MS/MS quantitative results were obtained in the 
product salt, sludge, and post-salt solvent samples.  Compounds that were detected 
included methamphetamine, pseudoephedrine, ephedrine, and CMP.  Based on the 
results, the analytical instrument of choice was successful in characterizing each aspect of 
a One Pot synthesis.  In addition to obtaining values of yield within the 
methamphetamine final product, concentrations within One Pot method waste were 
collected to understand contamination potentials for individuals in the immediate area.  
Also, contamination potential exists for the environment, assuming negligent disposal of 
clandestine laboratory waste.  And in summary, values were obtained for two commonly 
used One Pot method solvents, thus providing comparisons, as well as a more in-depth 
and characteristic interpretation of clandestine methamphetamine laboratories. 
For the product salt samples, no statistical difference in yield was present.  The 
minimal detection of the byproduct CMP, and absence within clandestine 
methamphetamine samples, could indicate the solvent used within the One Pot reaction.  
According to the literature, “The protons required for the reduction of the hydroxyl group 
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and the partial reduction of the aromatic ring arise because of damp or impure solvents or 
even water absorbed into the reaction from the atmosphere.”25  Therefore, the amount of 
water present within the One Pot reaction can impact the levels of CMP produced.  
However, careful precautions within the methodology of this study were taken to ensure 
equal treatment of both solvent types.  In discussions about the differences in the solvent 
types, diethyl ether versus camp fuel, a former DEA chemist explained the fact that any 
water added, present, or produced within the reaction is more easily soluble in diethyl 
ether.36  As a result, any methamphetamine produced is more likely to continuing 
reducing into CMP when suspended in diethyl ether versus camp fuel.  An equal amount 
of water was added to the camp fuel syntheses, which explains CMP being still produced.  
The byproduct concentrations are much lower in the camp fuel syntheses because the 
methamphetamine did not come into contact with water as readily due to camp fuel’s 
immiscibility with water.  Another contributing factor may be the duration of the One Pot 
reaction.  All controlled syntheses were performed over a period of two hours.  With 
knowledge that camp fuel does not allow CMP to be produced as easily, future tests of 
extending the reaction time may increase the formation of CMP. 
The trend of lower CMP detections in the other sample types, sludge and post-salt 
solvent, continued with the camp fuel reactions.  In fact, CMP was not detected in camp 
fuel waste samples.  For sludge comparisons of solvent type, there were no statistically 
significant differences for the other compounds present.  All p-values generated were 
above a 0.5 value.  However, all sludge samples were much more concentrated with 
target compounds, units of mg/mL, when comparing them to the other sample types, units 
of ng/mL.  This phenomenon cannot be fully explained and will require additional 
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research, but one hypothesis is that the de-pressurized One Pot allotted waiting time 
before the salting out process allowed the drug compounds to settle towards the bottom of 
the reaction vessel.  Since the solvent was decanted into a separate container the 
following day, a higher concentration of compounds may be present in residual solvent 
present in the sludge samples. 
For post-salt solvent comparisons of solvent type, every compound targeted was 
statistically different, with two compounds categorized as highly different and another 
categorized as extremely different.  In order of statistical difference, pseudoephedrine, 
methamphetamine, and ephedrine had p-values of 0.025, 0.003, and 0.000, respectively.  
Despite the statistical differences between the diethyl ether and camp fuel post-salt 
solvents, the percentages of drug compounds present, at an observational level, seem to 
be relatively consistent.  This similarity may imply that while the conversion of 
pseudoephedrine and ephedrine to methamphetamine was comparable, differences within 
the post-salt solvent samples can be attributed to another aspect of the One Pot method 
process.  Two potential sources of the deviation are the salting out process and filtration 
of product from solvent.  Further studies will need to be conducted to confirm and better 
understand the variability. 
 Overall, the One Pot methamphetamine method, in two variations based on 
solvent type, was characterized using LC-MS/MS.  The syntheses performed at OSU-
FTTL were representative of a clandestine laboratory procedure, adjusted slightly for 
safety precautions within a research facility.  An important note is that clandestine 
laboratory reactions are likely to be highly variable in regards to the amount of 
ingredients used and reaction duration.  Until more research is gathered, any 
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interpretations of illicit methamphetamine samples should focus more on the presence of 
specific compounds, instead of compound quantities.  Based on this study’s results, a 
signature byproduct of the One Pot reaction, CMP, as established in the literature, was 
successfully quantitated in diethyl ether syntheses, for both product and waste samples.  
CMP was also detected in trace amounts within camp fuel syntheses product samples.  
With the likelihood of high procedural and production variability within clandestine 
laboratories, the absence of CMP within this study’s camp fuel waste samples cannot 
exclude CMP from being present in clandestine laboratories that utilize camp fuel.  The 
study’s findings contribute knowledge and awareness to both the law enforcement and 
scientific communities towards the goal of improving detection and tracking capabilities 
of One Pot clandestine laboratories.  In addition, the target compounds detected in One 
Pot waste materials indicates a real possibility of contamination within the surrounding 
area and in the environment.  However, the ability to detect product methamphetamine, 
precursor pseudoephedrine, and byproduct CMP (diethyl ether samples only) in 
manufacturing waste, provides an opportunity to track the location of clandestine One Pot 
laboratories within the community via waste disposal routes. 
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CHAPTER III 
 
 
ONE POT WASTE DEPOSIT SIMULATION – SEWAGE EFFLUENT ANALYSIS 
3.1 Introduction 
Methamphetamine has manufactured into a continual problem over the past 
several decades.  Despite the dangers and health risks commonly associated with the 
stimulant’s use, individuals can easily produce methamphetamine in an area of their 
choosing, thus creating clandestine, or secret, laboratories.  From 2004 to 2011, the Drug 
Enforcement Administration (DEA) reported an estimate of over 85,000 
methamphetamine laboratory incidents.37  Among these statistics, Tulsa County in 
Oklahoma proved to be the national leader of incidents over the 8-year time period.  
However, other areas of the United States of America have experienced similar 
methamphetamine popularity, even in more recent years.  According to the World Drug 
Report, over 30,000 clandestine methamphetamine laboratories have been detected across 
the nation from 2011-2014.38 
Examination of clandestine methamphetamine laboratories over the course of 
time has shown multiple techniques for producing the drug of interest.  While new 
production methods may be a result of increased yield or simplicity, the major reason to 
develop new techniques has been after legislative restriction on the manufacturing 
ingredients.33  Recently, the One Pot methamphetamine method has become the most 
43 
 
common manufacturing process.  Along with a short and simple procedure, the One Pot 
method is popular due to the use of obtainable household ingredients.  Pseudoephedrine, 
the starting material in the One Pot method, is the only item that may provide an 
acquisition challenge.  As mentioned earlier, legislation has attempted to restrict access to 
methamphetamine production ingredients.  Many states, in an attempt to reduce the 
number of clandestine methamphetamine laboratories, have limited the amount of 
pseudoephedrine that an individual can purchase.39  Since pseudoephedrine is still 
available in limited quantities, in part for its medicinal decongestive properties, 
individuals are still utilizing the One Pot methamphetamine manufacturing method.  In 
fact, most of the seized domestic laboratories in 2014 were determined to be One Pot or 
“Shake and Bake” methamphetamine labs.40 
 Continual popularity of methamphetamine laboratories does not reduce associated 
dangers.  The One Pot method, like an older methamphetamine manufacturing procedure 
called the Birch Reduction method, explained in Chapter 2, uses lithium as an electron 
source to reduce the hydroxyl group of pseudoephedrine, thus creating 
methamphetamine.27  Lithium and other ingredients involved in the One Pot method, like 
a flammable organic solvent, causes the methamphetamine production to become 
severely dangerous.  Environmental exposure and the possibility of a fire are two risks 
introduced to the nearby community.  Even with successful methamphetamine cooks, 
toxic waste disposal can have detrimental effects to the surrounding area and residents.  
According to some reports, approximately five to seven pounds of waste accompanies 
every pound of methamphetamine produced.41  Common disposal routes include trash 
service, negligent dumping into outdoor areas, and introduction to the waste water 
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system.  While waste disposal has case-by-case variability, several reports and case 
studies prove that methamphetamine laboratory waste has been deposited in sink drains, 
flushed down toilets, etc.  One police detective wrote that it is not uncommon for 
methamphetamine laboratory individuals to pour toxic liquids down the drain in order to 
avoid detection.42  Before this study, the possibility of using waste water to locate 
methamphetamine laboratories had yet to be determined. 
Trace detection of drugs in waste water, as further discussed in the following 
section, has been primarily used to monitor pharmaceutical and illicit drug use in a 
community.  Parent, or unaltered, drug compounds and metabolites have successfully 
been detected in small amounts utilizing various sample extractions and analytical 
instrumentations.  While waste water analysis has contributed to understanding 
population drug trends and/or waste water treatment improvements, the possibility of 
detecting drug compounds to identify or assist in identifying clandestine laboratories has 
yet to be investigated.  The focal points of this research are to first, identify the potential 
hazards and health impacts of exposure to One Pot methamphetamine and manufacturing 
byproducts.  A second goal is to determine the possibility of monitoring One Pot 
methamphetamine laboratory products and waste materials after introduction to the waste 
water system.  And the last goal is to confirm or deny the usefulness of CMP as a unique 
identifier of methamphetamine manufacturing. 
Simulated One Pot methamphetamine laboratory products were developed and 
produced at the Oklahoma State University – Forensic Toxicology and Trace Laboratory 
(OSU-FTTL).  Methamphetamine product salts were produced, filtered, and removed.  
All remaining reaction waste, both solids and liquids, were deposited into a local waste 
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water system.  Time course waste water samples were collected downstream using an 
autosampler provided by the Savannah River National Laboratory (SRNL).  Sample 
analysis included solid phase extraction (SPE) followed by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) to quantitate target compounds within sewage 
effluent.  Results proved the ability to detect methamphetamine, pseudoephedrine, and 
over-reduced methamphetamine, CMP.  Analyses provided additional information, such 
as concentration levels and window of detection within sewage effluent.  This research 
demonstrated the possibility and potential of monitoring clandestine One Pot 
methamphetamine laboratories in the community through the use waste water analysis.  
In combination with continued research, the following study provides a method for law 
enforcement to assist in proactively detecting and seizing clandestine drug laboratories in 
the community. 
3.2 Review of the Literature 
 The One Pot method has become the primary method of choice for quick 
methamphetamine production.  Similar to all drug production methods that came before, 
laboratory waste can be a huge concern.  With the continual number of clandestine 
methamphetamine laboratories in communities, the possibility of environmental exposure 
to harmful and toxic chemicals has drawn public attention.  This awareness has 
developed a need to locate and consequently, eliminate One Pot methamphetamine 
laboratories within states, cities, and neighborhoods.  Identification of clandestine drug 
operations has been limited to first-hand reports, gathered intel, or laboratory incidents 
that reveal the presence of methamphetamine production.  For example, a study 
conducted in 2013 determined that trace amounts of methamphetamine and 
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pseudoephedrine could be detected following a methamphetamine laboratory fire.43  
While these results provided a useful tool for investigators, any and all law enforcement 
action would take place post-discovery of a clandestine drug laboratory. 
A need has been identified to assist in location of One Pot methamphetamine 
laboratories before potential environmental exposure.  Proactively seeking clandestine 
laboratories, especially those utilizing the One Pot method, has produced limited success.  
Although the Drug Enforcement Administration reported over 9,000 methamphetamine 
laboratory discoveries in 2014, many clandestine operations may continue to be kept in 
secrecy.40  The high availability of the One Pot method ingredients reduces the 
effectiveness of product monitoring.  Therefore, other means of clandestine laboratory 
identification must be researched. 
Of all the possible routes of disposing clandestine laboratory waste, the sewage 
system provides the most optimistic pathway for the law enforcement and scientific 
communities to achieve remote detection.  As noted in the introductory section, 
individuals have been known to pour methamphetamine and manufacturing waste down 
household water drains to avoid detection.  Figure 9, below, is an image taken by a police 
officer in Gladwin City, Michigan.  According to the news report, the police discovered a 
One Pot methamphetamine laboratory in a household kitchen.44 
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Figure 9. Police image of One Pot laboratory within kitchen sink.  Figured obtained from Dan Firnbach, 2015. 
Of significant importance is the use of the sink to perform the methamphetamine 
synthesis.  Whether the individual was pouring any unwanted materials down the drain, 
or just utilizing the sink as a receptacle for any chemical spills, One Pot 
methamphetamine waste is likely to reach the sewage system.  Another case, which 
provides more concrete proof of clandestine laboratory waste being introduced to the 
sewage system comes from a former Chief of Police in Stillwater, Oklahoma.  At one 
particular scene, the sink drain pipes were severely corroded due to methamphetamine 
waste exposure, to a point where the sink drain could not be used.  Therefore, the 
individual in this circumstance configured a piece of tubing from the sink to the drain of 
the dishwasher so that methamphetamine waste could be washed away.45  The 
configuration at this clandestine laboratory is shown in Figure 10, specifically the right 
side of the image where a single piece of white tubing can be observed. 
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Figure 10. Image taken at clandestine methamphetamine laboratory. On the right-hand side, a piece of white tubing 
was installed to run from the sink to the dishwasher drain.  Image was obtained by Ronald Thrasher, 2016. 
While case-by-case variability exists between clandestine methamphetamine laboratories, 
the examples provided confirm the sewage system to be a utilized method of waste 
disposal.  And consequently, the research at hand, has sought to determine if the 
detection of One Pot methamphetamine waste within sewage samples is possible. 
 Historically, analysis of community waste water has been conducted to identify 
population drug trends, monitor the effectiveness of waste water treatment facilities, etc.  
The primary reason pharmaceuticals and illicit compounds can be detected within waste 
water is the simple concept that individuals use drug compounds, and then excrete said 
compounds through urine and feces.  Therefore, a direct correlation can be made based 
on drug levels detected within waste water and human consumption.  Primarily, the 
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methods utilized to perform this type of research include SPE and gas chromatography-
mass spectrometry (GC-MS) or LC-MS/MS, although others techniques exist.  SPE is a 
sample preparation technique that uses a solid packing material within a column to 
separate different chemical compounds within a sample.46  In addition to the ability to 
separate and/or isolate target drugs, SPE typically concentrates the compounds.  A larger 
volume of sample is added to a SPE cartridge than is eluted as a final prepared sample for 
analysis.  Essentially, and ideally, all of the target drug compounds within a sample will 
be captured by the solid packing material within the SPE cartridge.  As a result, the more 
sample added to the cartridge, the higher the concentration of drug compounds within the 
sample analyzed.  For this reason, and the purpose of purifying dirty waste water, SPE 
has been the primary sample preparation technique within this area of research. 
 As explained above, sewage waste, commonly referred to as effluent, has been 
used in many instances to detect trace amounts of pharmaceuticals and illicit compounds.  
Among these studies include methamphetamine.  When performing waste water studies, 
additional information, such as the drug’s interaction with the body and excretion from 
the body, can be crucial to instrumental detection and result interpretation.  Many sewage 
effluent drug studies include methamphetamine, but in addition to monitoring the parent 
compound, amphetamine levels are examined as well.  “Between 30-54% of an oral dose 
is excreted in urine as unchanged methamphetamine and 10-23% as unchanged 
amphetamine.  Following an intravenous dose, 45% is excreted as unchanged parent drug 
and 7% amphetamine.”47  With this, drug metabolism as well as route of administration 
are important factors in result interpretation.  However, methamphetamine to 
amphetamine ratios in sewage water will not likely follow expected or theoretical values 
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due to other potential sources of these compounds.  Amphetamine is available as a 
prescription drug.  Increased use of this prescription drug in a given area or population 
would increase amphetamine concentrations in sewage effluent, thus creating a challenge 
for methamphetamine to amphetamine ratio determinations.  A second possible 
contributor to increased concentrations include compounds that metabolize to 
amphetamine or methamphetamine.  According to one report, benzphetamine, selegeline, 
and famprofazone are among this group.47  While the aforementioned substances may not 
be commonly used, the knowledge of their potential impact is important to consider when 
reviewing waste water results. 
Another important source of methamphetamine is those using the stimulant as 
prescribed.  Desoxyn is the only brand name methamphetamine available via 
prescription.  With LC-MS/MS analysis, Desoxyn use cannot be distinguished from illicit 
use.  An abundance of legal Desoxyn users within a given area, may skew illicit 
consumption interpretations.  However, a method to predict the amount of prescription 
methamphetamine use has been implored in the literature.  A study conducted in 2011, 
for example, focused on the interpretation of methamphetamine concentrations in sewage 
effluent.48  This group utilized DEA drug records to estimate the amount of prescription 
methamphetamine used within a population.  Since Desoxyn is not a commonly 
prescribed drug and sewage effluent analysis is highly variable to begin with, conclusions 
from this study indicated that calculated Desoxyn intake and excretion values would, for 
the most part, confidently estimate the amount of prescription methamphetamine present 
within the total methamphetamine concentration found in waste water.  The 
aforementioned study estimated that in a particular region of the State of Washington, 
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only 3-8% of the methamphetamine found in waste water could be attributed to 
Desoxyn.48  Although this value is theoretical and dependent on prescribed individuals 
ingesting and excreting Desoxyn within the given area, it provides a relatively close 
estimate of the maximum prescription methamphetamine that could be introduced to 
sewage effluent. 
The last potential contributor to methamphetamine within waste water, which is 
the focal point of this chapter, are clandestine production laboratories.  As explained 
above, the One Pot methamphetamine production method is the primary technique of 
choice among clandestine laboratories.  Additionally, each manufacture of 
methamphetamine has associated waste.  Based on the results from Chapter 2, trace 
amounts of product and byproducts are contained within the waste materials.  If 
individuals are disposing One Pot reaction waste down a sink drain, toilet, bath tub, etc., 
methamphetamine and related manufacturing compounds would be introduced to sewage 
effluent. 
Despite the many factors and sources of methamphetamine into the sewage water 
system, the majority of studies attempting to monitor the use of methamphetamine 
typically report the total concentrations found.  For the purposes of this review, only 
studies involving methamphetamine will be discussed.  In 1999, Daughton, one of the 
pioneers of waste water research, and a co-author Ternes, published a review that 
essentially established the demand to detect pharmaceuticals in the environment.49  
Following this call for research, several groups, across the United States and 
internationally, began creating waste water projects.  Recent work begins in 2008, where 
a group developed a special technique to combine SPE and LC-MS/MS into one 
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workflow system.  SPE was performed in such a way that the final step of eluting the 
target compounds with a sample, traveled directly into the LC-MS/MS.  Based on the 
results, Postigo et al. were able to reach a limit of detection (LOD) within waste water for 
amphetamine, methamphetamine, and ephedrine at 0.34, 0.28, and 0.78 ng/L, 
respectively.  And the limit of quantitation (LOQ) within waste water for the same 
compounds were 0.92, 0.75, and 2.21 ng/L, respectively.50  An important note in this 
project’s methodology is the use of only 5 mL per sample, which is likely attributed to 
the combined SPE and LC-MS/MS system.  The authors referenced that previous 
research typically used between 100 and 500 mL of sample.50  Another impactful finding 
from this project was the fact that the analysis of fortified chemistry-grade water 
produced significantly better results than analysis of waste water samples.  In conclusion, 
this result demonstrates that the waste water itself, is suppressing the ability to detect 
certain drug compounds.  In 2014, research was done to further investigate the identified 
suppression.  According to Ostman et al., a 45-78% signal repression of drugs exists 
within waste water analysis when compared to chemistry-grade water.51  Further 
research, such as altering methodology, will need to be completed to avoid or reduce the 
suppression. 
While the research projects above demonstrated signal suppression and potential 
drug LOD and LOQ values in waste water utilizing LC-MS/MS, another research group 
utilized GC-MS/MS to perform a similar study.  Gonzalez-Marino et al. compared and 
determined the LOD of various drug compounds for different water sample types: river 
water, treated waste water, and raw waste water.  The LOD values for amphetamine were 
determined to be 0.8, 3, and 7 ng/L, respectively, while the LOD values for 
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methamphetamine were 2, 7, and 7 ng/L, respectively.52  The detection cutoffs are not as 
low as seen with LC-MS/MS, but this research demonstrates the ability to use different 
instrumentation to achieve analytical detection.  An additional benefit, as noted by the 
authors, is that GC-MS/MS allows for a full spectra scan, which may be helpful in 
research designed to detect as many drug compounds as possible.  For a more direct 
comparison of GC-MS and LC-MS/MS, Mwenesongle et al. performed a study in 2013 
comparing the two instruments in regards to the ability to monitor drugs of abuse and 
their metabolites using SPE followed by GC-MS.  The results showed that GC-MS, in 
this instance, produced better results than the LC-MS/MS.  The LOQ for 
methamphetamine was 0.33 picograms using GC-MS, and 208 picograms with LC-
MS/MS.  Although this finding contradicts previous literature, it confirms the ability of 
both instruments to detect trace amounts of methamphetamine within waste water. 
In addition to research performed to determine the capabilities of analytical 
instrumentation to quantify drugs of interest within waste water, other projects were 
being conducted to determine drug consumption trends.  In 2009, Banta-Green et al. 
utilized waste water analysis to survey drug trends, particularly cocaine, 
methamphetamine, and ecstasy, within a chosen population.  Study design and results 
primarily focused on regions within the population, and categorized them as urban, 
suburban, and rural areas.  Indicators and metabolites of cocaine and ecstasy were more 
prominent in urban areas, but methamphetamine was present equally in all areas.53  Not 
only do these findings demonstrate a successful campaign to detect target drug 
compounds, but they also contribute to the confirmation of methamphetamine prevalence.  
Shortly after this research, another group focused on illicit substances as well, but had the 
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goal of determining day-to-day consumption patterns.  Zuccato et al. established that 
“party-drugs” such as cocaine and ecstasy were more prominent in waste water collected 
over the weekend as opposed to weekdays.  Conversely, methamphetamine demonstrated 
similar concentrations throughout the entire week.54  Another finding was the upward 
trend of methamphetamine concentrations within waste water from 2005-2009.54  While 
these two findings contribute to the capability of detecting drugs within sewage effluent, 
the results also elaborate on methamphetamine prevalence within the community, similar 
to the conclusions mentioned above. 
In summary, many studies within the literature provide examples and processes of 
analyzing both pharmaceutical and illicit compounds in waste water samples.  
Additionally, several studies have focused on the amount or concentrations present for 
specific compounds.  As for methamphetamine, the studies above demonstrate high and 
continued prevalence within populations.  However, the methamphetamine values 
obtained were attributed solely to human consumption.  The research groups discussed 
above either mentioned the potential for other sources of methamphetamine, or ignored 
the fact completely.  As stated earlier, another source of methamphetamine into sewage 
effluent is clandestine laboratories.  Whether individuals are dumping methamphetamine 
product down the drain to avoid detection, or discarding manufacturing waste, indicators 
of such activity could be identified via waste water analysis.  Again, the overall goal of 
this chapter is to determine the possibility of detecting One Pot method identifiers within 
waste water as a means to locate the presence of a clandestine laboratory. 
The One-Pot methamphetamine waste has only been quantitatively characterized 
in the findings presented in Chapter 2.  Based on LC-MS/MS results, the target 
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compounds to identify the presence of methamphetamine manufacturing would be 
methamphetamine, pseudoephedrine, ephedrine, and CMP.  Since three of the four 
compounds present within One Pot manufacturing waste are commonly used and 
excreted drugs, a challenge exists in distinguishing drug consumption versus drug 
production.  On the other hand, methamphetamine detection, in conjunction with the 
detection of other manufacturing byproducts, could indicate the presence of 
methamphetamine manufacturing.  Since CMP was also identified within One Pot waste, 
the detection of this byproduct may prove to be a key indicator of a clandestine 
laboratory.  The waste water analysis also needs to examine amphetamine, due to the 
result of metabolism.  Methamphetamine, in most instances, will be excreted 50% 
unchanged or un-metabolized, while 10-20% of the methamphetamine will be converted 
to amphetamine before excretion.47  Although the focal point of the waste water results 
will be on the concurrent detection of methamphetamine and CMP, the amount of 
amphetamine present may reveal the quantity of methamphetamine that should be 
attributed to human consumption.  Based on review of the literature, no research has been 
conducted on sewage effluent to detect the presence of methamphetamine manufacturing.  
As explained earlier, the prevalence of One Pot methamphetamine has created a public 
and environmental safety demand to proactively find clandestine laboratories.  With 
knowledge of negligent dumping of hazardous reaction waste into sewage effluent, waste 
water analysis may provide a means to locate and consequently remove One Pot 
clandestine laboratories from communities before they can cause more harm to innocent 
bystanders. 
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3.3 Methodology 
Two side-by-side One Pot reactions were completed over a course of four days 
for a total of 8 syntheses, labeled EE1-EE4 and CE1-CE4; “EE” and “CE” respectively 
indicate “Ether Effluent” or “Camp Fuel Effluent” and the number indicates the 
sequence.  Following each reaction, lithium was removed and placed into 250 mL water 
in a container labeled with the appropriate One Pot reaction designation and deemed 
“lithium-in-water solution.”  Sludge and post-salt solvent samples were collected as 
described above in the methodology section of Chapter 2.  Pre-salt solvent was 
completely purged with hydrogen chloride gas and the filtered product salts were 
removed and stored solely for laboratory analysis.  In total, the One Pot reaction waste 
materials recovered from each of the 8 methamphetamine salt syntheses included: 
1) lithium-in-water solution, 
2) sludge, 
3) post-salt solvent. 
These three liquid solutions together constituted the full methamphetamine production 
waste from each One Pot reaction.  EE1-EE3 and CE1-CE3 materials were set aside for 
subsequent, controlled deposit into a municipal sewage water system.  EE4 and CE4 were 
stored for laboratory characterization analysis as described in Chapter 2. 
 A municipal lift station located within a mixed zone of commercial and industrial 
buildings was chosen for sewage water sampling to attempt detection of the three 
prepared liquid components of One Pot laboratory waste generated per synthesis.  The 
gravity-fed lift station is described as low flow (roughly 1500-3000 gallons per day) and 
discharges to a 4-inch forced main.  The lift station is comprised of an underground 
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concrete catchment tank, or wet well, which collects sewage water from the surrounding 
commercial-industrial zone.  The wet well is open to atmosphere and is fitted with a 
ground level hatch opening, raised in the interior image seen in Figure 11. 
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Figure 11. Interior view of wet well at low flow lift station. 
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The wet well is equipped with submerged pumps to periodically pump the sewage water 
to a higher elevation, ultimately directed towards the sewage water treatment plant, with 
at least one additional and larger lift station downstream ahead of the waste treatment 
plant in the municipality. 
Lift station historical data logging statistics from the one-month time period prior 
to the field study indicate approximately 3-4 pumpdowns of the wet well occur per day.  
A pumpdown is the initiation of water pumps that activate when the water level in the 
wet well reaches a certain maximum level.  The pumps will continue pushing water out 
of the lift station until a minimum water level is reached, thus ceasing the pump down.  3-
4 pumpdowns is an average number for this site, but 6 discrete pump starts were reported 
to have occurred prior to one study day.  Also available was an estimated discharge of 
2666 gallons over the 6 reported pumpdowns for that day, so 444 gallons may be 
calculated as an approximate volume per pumpdown.  A monthly average suggests a 
similar value of 438 gallons per pumpdown.  An important note is the presence of a large 
unknown volume of sewage water remaining in the wet well after each pumpdown.  
Provided lift station design drawings suggest if roughly 400-450 gallons are pumped out 
of the wet well as reported each pump cycle, that would closely match the volume that 
always remains in the bottom of the well, serving, in part, as an important cooling fluid 
surrounding the submersible pumps.  Therefore, any compound concentrations generated 
from laboratory results may potentially be skewed due to this unknown variable.   
Prior to any experiments, several tests were performed to ensure experimental success.  A 
24-cartridge automated waste water sampler (Teledyne ISCO, Model 3700, Lincoln, NE) 
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was installed.  The autosampler was placed at ground level beside the lift station wet well 
hatch opening, see Figure 12. 
 
Figure 12. Automated waste water sampler placed at ground level beside wet well. 
The autosampler was modified to integrate a level transmitter and small programmable 
electronic controller to sense falling water in the wet well and direct the sampler to 
collect one sample during each pumpdown of the wet well; however, this modification 
was unsuccessful during the study.  Another autosampler program is collection of waste 
water samples at designated time intervals, which demonstrated repeated success when 
set to collect a sample every 15 minutes.  Next, dye tests were performed to identify 
sewage water travel time to the lift station from the selected manhole One Pot waste 
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material deposit site.  Fluorscein Green Dye (Brainerd Chemical Company, Tulsa, OK) 
was deposited into the sewage manhole located 646 feet upstream, and visible indication 
of dyed water entry to the wet well, see Figure 13, was observed 21.5 minutes later. 
 
Figure 13. Lift station wet well sewage inflow point during dye test. 
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A second dye test was performed the following day to ensure a similar flow pattern and 
rate from the designated manhole upstream to the lift station.  No visual time recordings 
were documented, but observation of the autosampler bottles indicated a similar travel 
time between 15-30 minutes.  Figure 14, below, demonstrates the observation of green 
dye present in the fourth autosampler bottle.  Bottle 1 was collected prior to the dye test, 
Bottle 2 was collected at the initiation of the dye test, and Bottle 3 was collected 15 
minutes.  Since Bottle 4 was collected 30 minutes post-initiation, the green dye reached 
the lift station at some moment between Bottle 3 and 4, i.e. 15-30 minutes.  Following 
success of autosampler installation and programming, and subsequent dye tests, 
simulated One Pot methamphetamine waste disposal could be explored. 
 
Figure 14. Collected Waste Water Samples Within Autosampler Rack.  Green dye test initiated at the collection of 
Bottle 2, followed by 15-minute interval collections.  Green dye present in Bottle 4 indicates a manhole to lift station 
travel time of 15-30 minutes. 
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One Pot methamphetamine reaction wastes were deposited once per day, over a 
Tuesday, Wednesday, and Thursday period, into the street manhole located 646 feet 
upstream of the low flow lift station over two consecutive weeks; diethyl ether reaction 
wastes, EE1-EE3, were deposited the first week, camp fuel wastes, CE1-CE3, the 
following week.  One Pot reaction wastes were deposited each morning immediately 
following collection of a background sewage water sample with the 24-cartridge 
automated waste water sampler mentioned above. 
 After a background sample was collected each morning, One Pot waste liquids 
were then deposited.  The deposits included three One Pot waste products previously 
explained, lithium-in-water solution, sludge, and post-salt solvent.  Following initiation 
of each experiment, 500 mL of sewage water were collected at 15-minute intervals from 
the downstream lift station wet well for a period of three to four hours, resulting in 12-16 
“Time Course” samples collected.  Time Course samples were labeled with the 
corresponding synthesis designation, EE or CE and reaction number, followed by a 
period and autosampler bottle number.  The bottle number corresponded to the 
chronology at which the sewage water sample was collected.  Bottle 1 was collected as a 
background sample pre-deposit, Bottle 2 was collected at time equals 0 minutes, Bottle 3 
was collected at time equals 15 minutes, and so on, in chronological order. 
At mid-day, the Time Course sampling was halted and the autosampler was then 
set to collect a sample upon receiving a “Pulse” signal from detection of falling water in 
the wet well, i.e. a pumpdown event, reducing the sample collection burden over the 
remainder of a 24-hour total collection period per waste deposit.  However, this 
modification was unsuccessful during the study as previously mentioned.  The Pulse 
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program of the autosampler was inconsistent, and resulted in variable collection of 
samples, if any, during each deposit experiment.  Any Pulse samples collected were 
labeled following the same chronological pattern as mentioned above, but the bottle 
numbers began sequentially after the last Time Course sample collected for that specific 
deposit.  For example, if the last Time Course sample was collected in bottle 12, the first 
Pulse sample collected would be labeled as 13, with of course, additional designating 
information like solvent type and deposit number. 
A sampling summary, of both Time Course and Pulse samples, can be found in 
Table 11.  All samples listed below were transferred to new and separate containers for 
transport back to OSU-FTTL.  Each sample was stored in a freezer until laboratory 
analysis. 
Table 11. Sewage Water Sample Collection.  Included for each One Pot methamphetamine waste deposit are the date, 
time of deposit, sample collection start time, number of time course samples collected, and number of pulse samples 
collected. 
Deposit Date 
Deposit 
Start Time 
Sample Collection 
Start Time 
Time Course 
Samples 
Pulse 
Samples 
EE1 7/26/16 8:20 AM 8:05 AM 12 0 
EE2 7/27/16 7:35 AM 7:24 AM 15 7 
EE3 7/28/16 7:26 AM 7:18 AM 16 24 
CE1 8/2/16 7:29 AM 7:19 AM 12 0 
CE2 8/3/16 7:29 AM 7:21 AM 12 10 
CE3 8/4/16 7:29 AM 7:23 AM 12 16 
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 For SPE, the following materials and machines were utilized: Oasis MCX 3 cc 
cartridges (Waters Corporation, 60 mg, 30 m), CEREX 48 Flow Control (SPEware 
Corporation, Baldwin Park, CA), and CEREX 48 Sample Concentrator (SPEware).  The 
following solutions were utilized: Internal Standard Mix (1000 ng/mL solution of all four 
deuterated internal standards in LC-MS grade water), 10 mM hydrochloric acid solution 
prepared with 37% HCl and LC-MS grade water, LC-MS grade methanol, and Mobile 
Phase A.  For every sample, 10 L of Internal Standard Mix and 200 µL of 10 mM 
hydrochloric acid solution were added to 2 mL of sample.  Following sample preparation, 
Table 12 ,below, outlines each section of the solid phase extraction procedure.  SPE 
cartridges were conditioned prior to sample addition.  After a rinse step, cartridges were 
dried under positive pressure for 20 minutes at approximately 80 psi.  After being 
vacuum dried, elution buffer was added and the eluent was collected into labeled test 
tubes.  Samples were dried to complete dryness under nitrogen at 40 oC.  Reconstitution 
buffer was added to each test tube and following thorough vortexing, every sample was 
transferred to an LC injection vial for LC-MS/MS analysis.  The LC-MS/MS instrument 
methodology is the same as described in Chapter 2. 
Table 12. Solid Phase Extraction Procedure. 
SPE Step Parameter 
Sample Preparation 10 L Internal Standard Mix 
  200 L 10 mM HCL 
Condition 2 mL LC-MS grade methanol 
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  2 mL 10 mM HCL 
  2 mL 10 mM HCL 
Sample Addition 2 mL sample 
Rinse 2 mL 10 mM HCL 
Cartridge Dry Down 20 min at ~80 psi 
Elution 2 mL 2% ammonium hydroxide in methanol 
Elution Dry Down Under nitrogen at 40ºC 
Reconstitution 100 L Mobile Phase A 
The validation of the SPE method contained three tests: linearity, accuracy and 
precision, and matrix effects.  Each of these is explained below.  The quantitation ratios, 
the ratio of the larger transition area to the internal standard transition area, from the 
calibrators that met the identification criteria were plotted versus concentration.  After the 
data were plotted, they were fitted with a best fit line, and weightings were adjusted to 
assure the best correlation, or highest R-squared or R2 value.  The R2 for this line was 
required to be greater than 0.9.  For the calibration points to be included in this study, 
they had to have an accuracy and precision within 30% when applied to the line of best 
fit.  The limit of quantitation, or LOQ, was allowed to be within 30% for both accuracy 
and precision, though its instrument response had to be at least five times greater than the 
response of a blank.  The linear range for all non-internal standard compounds in the LC-
MS/MS method mentioned above contained the following calibrator points: 100, 50, 25, 
5, 1, 0.5, and 0.1 ng/mL of each drug compound. 
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Six replicates of the calibration curve were extracted and concentrations values 
were calculated for each calibrator.  Accuracy for each calibrator was calculated by 
averaging the concentration of the six replicates and dividing that average by the 
theoretical concentration of each calibrator.  Precision for each calibrator was calculated 
by dividing the standard deviation average by the calculation average and subtracting that 
value from 1.  R2 values for each calibration curve were obtained after applying a best fit 
line, and all values averaged for a given compound.  The concentration values, mentioned 
above, were obtained utilizing MultiQuant software (SCIEX, Foster City, CA), which is 
specifically designed for LC-MS/MS result analysis.  All other values and statistical 
parameters were obtained by utilizing Microsoft Excel (Microsoft Corporation, 
Redmond, WA). 
An accuracy and precision study was performed to provide information regarding 
the accuracy and precision, or variability, in the SPE process.  To pass the accuracy and 
precision study, the average values for each point had to be within 30% of the true value.  
Two quality control (QC) points were used for the accuracy and precision study.  QCA 
had a concentration of 50 ng/mL and QCB had a concentration of 1 ng/mL.  Each QC 
was analyzed four times a day for six days.  The first two analyses occurred at the 
beginning of the day and the second two occurred at the end of the day.  Values for QC 
points were obtained using MultiQuant software.  Concentrations for each QC analysis 
were used in Microsoft Excel to obtain accuracy, within-run precision, between run 
precision, intraday precision, interday precision and within-laboratory precision. 
Matrix effects are a type of assay interference caused by ion suppression or ion 
enhancement in the matrix.  To test for matrix effects, the analytical results of five 
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injections of compounds that did not undergo extraction, labeled as “neat,” were 
compared to injections of five individual water samples that were from different sources, 
were known to be free of the compounds of interest, and were fortified with compounds 
after extraction.  The neat and post-extraction fortified samples were designated as 
sample set 1 and sample set 2, respectively.  Matrix effect (ME) was calculated by 
dividing the average peak area of the water samples fortified after extraction by the 
average peak area of the compound in neat solution and multiplying by 100.  The ME 
value takes into account any ion suppression or enhancement.  The 10 ng/mL calibrator 
was used in this experiment.  To prepare sample set 1, methamphetamine, CMP, 
pseudoephedrine, ephedrine, and amphetamine drug standards, mentioned above, were 
diluted in deionized water at 200 ng/mL.  Although this concentration does not match the 
calibrator being using in this study, the fortification of the neat sample is increased to 200 
ng/mL to account for the simulation of a sample with 100% extraction efficiency, being a 
2 mL sample at 10 ng/mL.  For sample set 2, the known blank water samples were spiked 
with 200 ng/mL of the same five compounds used in sample set 1. 
 During the matrix effects study, recovery efficiency (RE) was also performed.  
RE demonstrates how well the sample is recovered during SPE.  To test for RE, the 
analytical results of five individual water samples from different sources, which were 
known to be free of the compounds of interest and were fortified at the 10 ng/mL level 
before extraction, designated as sample set 3, were compared to sample set 2 in the ME 
study.  RE was calculated by dividing the average peak area of water samples fortified 
before the extraction by the average peak area of water samples fortified after extraction 
and multiplying by 100. 
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 Process efficiency (PE) or how well the SPE process functions in the way of 
detecting the compounds of interest, was also determined during the matrix effects study.  
To test for PE, the analytical results of five injections of compounds that were in sample 
set 1 were compared to injections of five individual water samples that were in sample set 
3.  PE was calculated by dividing the average peak area of water samples fortified before 
extraction by the average peak area of the compounds in neat solution and multiplying by 
100. 
 Currently, there is no defined limit for acceptable matrix effects, recovery 
efficiency, or process efficiency.  For this study, a range of 60-140% was considered 
acceptable.  If values were out of the plus or minus 40% range when averaged across 
each matrix source, the compounds were evaluated in the other precision and accuracy 
studies to determine that there was sufficient sensitivity and selectivity in the method for 
sewage water analysis.  In summary, Table 13 outlines sample specifics in each sample 
set. 
Table 13. Matrix Effects Study Sample List.  Table includes the water sample source, as well as the concentration at 
which each sample was fortified with drug compounds of interest. 
Sample Set Water Sample Drug Concentration 
1 LC-MS Grade 200 ng/mL, un-extracted 
2 Source 1 200 ng/mL, post-extraction 
 
Source 2 200 ng/mL, post-extraction 
 
Source 3 200 ng/mL, post-extraction 
 
Source 4 200 ng/mL, post-extraction 
70 
 
  Source 5 200 ng/mL, post-extraction 
3 Source 1 10 ng/mL, pre-extraction 
 
Source 2 10 ng/mL, pre-extraction 
 
Source 3 10 ng/mL, pre-extraction 
 
Source 4 10 ng/mL, pre-extraction 
 
Source 5 10 ng/mL, pre-extraction 
Sewage water samples, selectively chosen from each One Pot waste deposit, were sent to 
SRNL for analysis.  The samples included a background sample from each deposit as well as two 
samples that were likely to exhibit the largest concentration of target compounds.  After arriving 
at SRNL, the waste water samples were dissolved and heated in 5% nitric acid in preparation for 
lithium analysis; sample weights and volumes are as listed in Table 14.  In addition, the table 
provides a list of which samples were sent to and analyzed by SRNL staff.  The dissolutions were 
analyzed on an Agilent 7700x Inductively Coupled Plasma Mass Spectrometer (ICP-MS) 
equipped with a helium collision cell.  High Purity standard solutions that consisted of 52 
elements at concentrations of blank, 1, 5, 10, 25, and 50 parts-per-billion (ppb) in 2% nitric acid 
were used to calibrate the instrument.  The dissolutions were diluted by a factor of ten in 2% 
nitric acid for analysis on the instrument. 
Table 14. Weight and volume of sewage water samples prepared for ICPMS analysis. 
Sample Sample Weight (g) Total Volume (mL) 
CE 1-1 4.83 100 
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CE 1-4 4.75 100 
CE 1-5 4.72 100 
CE 2-1 4.78 100 
CE 2-4 4.77 100 
CE 2-5 4.75 100 
CE 3-1 3.72 100 
CE 3-4 4.71 100 
CE 3-5 4.81 100 
EE 2-1 4.78 100 
EE 2-4 4.84 100 
EE 2-5 4.42 100 
EE 4-1 4.75 100 
EE 4-4 4.71 100 
EE 4-5 4.70 100 
EE 6-1 4.83 100 
EE 6-4 4.84 100 
EE 6-5 4.80 100 
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3.4 Findings 
Solid phase extraction with LC-MS/MS analysis was validated.  Tests included 
calibration and linearity, accuracy and precision, and matrix effects.  The following 
calibrators met criteria of linearity by having accuracy and precision values within 10%: 
100, 50, 25, 5, 1, and 0.5 ng/mL.  Table 15-Table 19 below demonstrate the accuracy and 
precision for all calibrator levels of methamphetamine, pseudoephedrine, ephedrine, 
amphetamine, and CMP.  The “Average” column refers to the average concentration, in 
ng/mL, of the 6 replicate runs.  Accuracy and precision are reported as percentages, with 
100% considered to be absolute.  Any value below or above true accuracy or precision is 
considered a suppression or enhancement of calibrator concentration, respectively.  All 
average concentrations of the blank were under 5 times that of the LOQ, which was 
determined to be 0.5 ng/mL for all compounds.  In the following sections, any value 
outside the calibration curve range are estimates based on the slope of each best fit line, 
but must meet identification criteria in order to be reported.  The best fit line was 
determined to be a power fit with no weighting. 
Table 15. Methamphetamine Linearity 
Methamphetamine 
Calibrator (ng/mL) Average 
Standard 
Deviation 
Overall 
Accuracy 
Overall 
Precision 
100 92.8 8.22 93% 92% 
50 53.1 7.09 106% 88% 
25 25.4 1.86 102% 93% 
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5 4.55 0.45 91% 91% 
1 0.94 0.10 94% 90% 
0.5 0.54 0.04 107% 94% 
Blank* 0.01    
R2 0.98    
Table 16. Pseudoephedrine Linearity 
Pseudoephedrine 
Calibrator (ng/mL) Average 
Standard 
Deviation 
Overall 
Accuracy 
Overall 
Precision 
100 96.6 9.37 97% 91% 
50 52.2 6.37 104% 89% 
25 26.0 2.34 104% 92% 
5 4.97 0.55 99% 90% 
1 0.91 0.10 91% 90% 
0.5 0.49 0.03 98% 94% 
Blank* 0.00  
R2 0.99  
Table 17. Ephedrine Linearity 
Ephedrine Calibrator (ng/mL) Average Standard 
Overall Overall 
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Deviation Accuracy Precision 
100 102 9.83 102% 91% 
50 52.3 3.49 105% 94% 
25 25.0 1.95 100% 93% 
5 4.65 0.30 93% 94% 
1 0.95 0.08 95% 93% 
0.5 0.52 0.04 104% 92% 
Blank* 0.08  
R2 1.00  
Table 18. Amphetamine Linearity 
Amphetamine Calibrator 
(ng/mL) Average 
Standard 
Deviation 
Overall 
Accuracy 
Overall 
Precision 
100 96.6 8.98 97% 92% 
50 51.6 3.74 103% 93% 
25 25.6 2.51 102% 91% 
5 4.85 0.27 97% 95% 
1 0.98 0.07 98% 93% 
0.5 0.53 0.06 107% 89% 
75 
 
Blank* 0.00  
R2 0.99  
Table 19. CMP Linearity 
CMP Calibrator (ng/mL) Average 
Standard 
Deviation 
Overall 
Accuracy 
Overall 
Precision 
100 106 17.73 106% 85% 
50 56.5 6.06 113% 90% 
25 25.4 3.69 102% 87% 
5 5.05 0.82 101% 85% 
1 1.03 0.11 103% 90% 
0.5 0.52 0.05 104% 92% 
Blank* 0.00  
R2 0.98  
 All QC averages except within-run precision and within-laboratory precision for 
CMP fell within 20% of the true value.  CMP’s within-run precision was 23.2% and its 
within-laboratory precision was 20.4%.  Additionally, all accuracy values for the QC 
points were within 15% of the true value.  See Table 20-Table 22, below, for all QC 
precision and accuracy values.  For all values listed, the precision results are that of 
imprecision, meaning a value of 0 is considered absolute precision.  Therefore, the closer 
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a value to zero, the more precise that QC point is for that specific compound.  For 
accuracy, a value of 100% is considered absolute.  
Table 20. Within-Run and Between Run Precision for QC points. 
 
Within-Run Precision Between Run Precision 
Compound QCA QCB QCA QCB 
Methamphetamine 6.26 15.0 12.2 10.1 
Pseudoephedrine 5.72 4.79 9.16 5.83 
Ephedrine 2.20 5.28 0.10 0.03 
CMP 16.5 23.2 0.13 0.09 
Amphetamine 3.33 8.19 7.57 3.96 
Table 21. Interday and Intraday Precision for QC points. 
 
Interday Precision Intraday Precision 
Compound QCA QCB QCA QCB 
Methamphetamine 3.96 6.44 11.4 3.36 
Pseudoephedrine 8.81 8.94 8.22 4.74 
Ephedrine 3.02 12.6 10.0 1.66 
CMP 3.94 8.56 6.22 14.0 
Amphetamine 10.5 16.1 7.19 0.00 
Table 22. Within-Laboratory Precision and Accuracy for QC points. 
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Within-Laboratory Precision Accuracy 
Compound QCA QCB QCA QCB 
Methamphetamine 13.6 16.0 105% 89% 
Pseudoephedrine 13.3 11.2 104% 97% 
Ephedrine 10.7 13.6 105% 99% 
CMP 18.1 20.4 113% 112% 
Amphetamine 13.2 17.6 106% 100% 
      All five compounds of interest passed the matrix effect (ME) study, but the same 
is not true for recovery efficiency (RE) and process efficiently (PE).  Methamphetamine 
and CMP both failed RE and PE tests, while amphetamine only failed PE.  All values 
listed in Table 23 were calculated using the peak area for all compounds.  All matrix 
effect samples had ME, RE, and PE corrected by dividing the peak area observed for 
each compound by the peak area of the corresponding internal standard.  The resulting 
ratio, known as the quantitation ratio, was then used in place of the respective sets used in 
ME, RE, and PE calculations.  The quantitation ratios obtained from the internal standard 
correction passed all ME, RE, and PE studies.  All ME, RE, and PE percentages for the 
peak area comparisons and the quantitation ratio comparisons are given in Table 24. 
Table 23. Matrix Effects, Recovery Efficiency, and Process Efficiency.  All calculations used peak areas for 
methamphetamine, pseudoephedrine, ephedrine, CMP, and amphetamine. 
 
Area 
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Compound Matrix Effects Recovery Efficiency Process Efficiency 
Methamphetamine 84% 55% 46% 
Pseudoephedrine 101% 78% 78% 
Ephedrine 93% 75% 70% 
CMP 99% 32% 32% 
Amphetamine 93% 62% 58% 
Table 24. Matrix Effects, Recovery Efficiency, and Process Efficiency.  All calculations used quant ratios for 
methamphetamine, pseudoephedrine, ephedrine, CMP, and amphetamine. 
 
Quant Ratio 
Compound Matrix Effects Recovery Efficiency Process Efficiency 
Methamphetamine 103% 105% 109% 
Pseudoephedrine 99.0% 96.5% 95.5% 
Ephedrine 98.4% 97.3% 95.8% 
CMP 117% 65.4% 76.4% 
Amphetamine 103% 98.9% 102% 
Time course samples were collected for every One Pot methamphetamine waste 
deposit.  These included three reactions using diethyl ether and three using camp fuel, 
labeled EE1-3 and CE1-3, respectively.  Table 25-Table 30 below lists all time course 
sample concentrations following SPE and LC-MS/MS analysis.  For all tables, samples 
are labeled with deposit type and number, followed by the autosampler bottle number 
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after the period.  As explained previously, Bottle 1 was collected before each deposit and 
the consecutive bottle numbers were collected at succeeding 15 minute-intervals.  All 
values listed are in ng/mL.  Any result listed below a value of 0.5 ng/mL, or the LOQ, is 
outside of the calibration range; however, an estimated value was listed if the 
chromatographic peak met identification criteria.  These values are denoted with a single 
asterisk in the tables below.  All negative samples are listed as 0.00. 
Table 25. EE1 Time Course Samples.  All values reported in ng/ml. 
Sample 
Time 
from 
Deposit 
(min) Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
EE1.1 -15 0.10* 0.09* 0.05* 0.00 0.25* 
EE1.2 0 0.09* 0.04* 0.02* 0.00 0.14* 
EE1.3 15 0.11* 0.05* 0.05* 0.00 0.20* 
EE1.4 30 5.37 1.78 7.67 0.70 0.18* 
EE1.5 45 2.16 1.02 3.65 0.35* 0.13* 
EE1.6 60 1.71 0.63 2.36 0.28* 0.17* 
EE1.7 75 1.13 0.43* 1.75 0.26* 0.12* 
EE1.8 90 1.24 0.43* 1.74 0.23* 0.15* 
EE1.9 105 1.17 0.36* 1.63 0.21* 0.16* 
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EE1.10 120 0.96 0.32* 1.26 0.17* 0.18* 
EE1.11 135 0.91 0.66 1.14 0.14* 0.14* 
EE1.12 150 0.80 0.38* 1.11 0.17* 0.38* 
Table 26. EE2 Time Course Samples.  All values reported in ng/ml. 
Sample 
Time 
from 
Deposit 
(min) Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
EE2.1 -15 0.34* 1.19 0.53 0.00 0.33* 
EE2.2 0 0.28* 1.54 1.08 0.00 0.29* 
EE2.3 15 0.27* 1.03 0.48* 0.00 0.28* 
EE2.4 30 0.31* 0.99 0.29* 0.00 0.30* 
EE2.5 45 3.09 1.73 5.74 0.28* 0.33* 
EE2.6 60 2.47 1.50 4.45 0.25* 0.30* 
EE2.7 75 5.10 1.97 10.0 0.44* 0.33* 
EE2.8 90 5.86 2.42 12.5 0.56 0.25* 
EE2.9 105 6.05 2.19 11.4 0.57 0.25* 
EE2.10 120 5.38 2.00 10.2 0.51 0.24* 
EE2.11 135 4.46 1.72 8.70 0.46* 0.24* 
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EE2.12 150 4.50 1.81 8.35 0.43* 0.24* 
EE2.13 165 3.24 1.38 5.99 0.33* 0.22* 
EE2.14 180 1.40 0.59 2.61 0.18* 0.18* 
EE2.15 195 1.33 0.62 2.43 0.14* 0.53 
Table 27. EE3 Time Course Samples. 
Sample 
Time 
from 
Deposit 
(min) Methamphetamine Pseudoephedrine Ephedrine CMP  Amphetamine 
EE3.1 -15 0.62 0.40* 1.01 0.00 0.26* 
EE3.2 0 0.60 0.34* 1.00 0.00 0.26* 
EE3.3 15 0.45* 0.29* 0.69 0.00 0.21* 
EE3.4 30 0.74 0.51 1.45 0.05* 0.28* 
EE3.5 45 6.90 2.41 13.8 0.35* 0.24* 
EE3.6 60 6.56 2.50 12.5 0.38* 0.19* 
EE3.7 75 4.23 1.35 7.35 0.24* 0.26* 
EE3.8 90 2.98 0.97 5.66 0.16* 0.19* 
EE3.9 105 2.91 1.06 5.42 0.17* 0.19* 
EE3.10 120 2.71 0.96 4.93 0.18* 0.21* 
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EE3.11 135 2.43 0.80 4.53 0.15* 0.24* 
EE3.12 150 2.19 0.73 3.87 0.13* 0.20* 
EE3.13 165 1.89 0.72 3.63 0.12* 0.17* 
EE3.14 180 1.62 0.54 2.97 0.13* 0.16* 
EE3.15 195 1.54 0.57 3.16 0.09* 0.61 
EE3.16 210 1.32 0.54 2.47 0.10* 0.39* 
Table 28. CE1 Time Course Samples 
Sample 
Time 
from 
Deposit 
(min) Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
CE1.1 -15 0.96 0.84 1.28 0.00 0.18* 
CE1.2 0 0.92 0.87 0.98 0.00 0.16* 
CE1.3 15 0.87 0.79 0.84 0.00 0.13* 
CE1.4 30 1.12 0.85 1.02 0.00 0.16* 
CE1.5 45 41.4 18.1 68.9 0.25* 0.21* 
CE1.6 60 18.0 7.11 26.3 0.17* 0.23* 
CE1.7 75 16.3 6.59 24.4 0.17* 0.21* 
CE1.8 90 15.4 5.78 22.2 0.13* 0.20* 
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CE1.9 105 14.8 8.37 22.0 0.15* 0.21* 
CE1.10 120 9.60 7.41 14.3 0.10* 0.16* 
CE1.11 135 7.83 6.83 11.2 0.08* 0.17* 
CE1.12 150 7.18 4.81 10.7 0.08* 0.14* 
Table 29. CE2 Time Course Samples. 
Sample 
Time 
from 
Deposit 
(min) Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
CE2.1 -15 0.74 1.53 0.94 0.00 0.15* 
CE2.2 0 0.74 1.41 0.90 0.00 0.14* 
CE2.3 15 0.55 1.08 0.64 0.00 0.10* 
CE2.4 30 1.43 2.38 3.55 0.00 0.14* 
CE2.5 45 17.1 18.9 88.4 0.19* 0.16* 
CE2.6 60 7.78 10.6 36.4 0.11* 0.14* 
CE2.7 75 6.50 7.48 25.1 0.10* 0.26* 
CE2.8 90 5.81 6.96 23.7 0.08* 0.24* 
CE2.9 105 5.06 7.05 21.7 0.05* 0.24* 
CE2.10 120 5.01 6.45 21.7 0.07* 0.22* 
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CE2.11 135 5.04 6.61 21.0 0.09* 0.22* 
CE2.12 150 3.78 5.37 15.4 0.00 0.19* 
Table 30. CE3 Time Course Samples. 
Sample 
Time 
from 
Deposit 
(min) Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
CE3.1 -15 0.32* 2.22 1.95 0.00 0.13* 
CE3.2 0 0.43* 1.70 1.95 0.00 0.09* 
CE3.3 15 0.41* 1.57 1.70 0.00 0.11* 
CE3.4 30 15.0 24.6 102 0.08* 0.12* 
CE3.5 45 11.9 18.7 75.2 0.10* 0.13* 
CE3.6 60 9.13 16.1 57.8 0.08* 0.13* 
CE3.7 75 7.62 12.4 53.2 0.07* 0.15* 
CE3.8 90 7.76 11.2 51.9 0.07* 0.15* 
CE3.9 105 6.99 11.0 47.6 0.06* 0.14* 
CE3.10 120 5.37 9.01 40.6 0.04* 0.12* 
CE3.11 135 4.56 6.76 30.5 0.00 0.11* 
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Additionally, Pulse samples were collected for deposits EE2, EE3, CE2, and CE3. 
EE1 and CE1 experienced sampling errors during the pulse collection period and no 
Pulse samples were collected by the autosampler.  Table 31-Table 34 below lists all Pulse 
sample concentrations following SPE and LC-MS/MS analysis.  For all tables, samples 
are labeled with deposit type and number, followed by the autosampler bottle number 
after the period.  The bottle number begins after each deposit’s Time Course sample 
count.  As noted previously, Pulse samples are chronological, but not associated with a 
known time within the final 20-21 hour collection window.  All values listed are in 
ng/mL.  Any result listed below a value of 0.5 is outside of the calibration range; 
however, an estimated value was listed if the chromatographic peak met identification 
criteria.  These values are denoted with a single asterisk in the tables below.  All negative 
samples are listed as 0.00. 
Table 31. EE2 Pulse Samples. 
Sample Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
EE2.16 0.32* 0.19* 0.76 0.00 0.25* 
EE2.17 0.29* 0.10* 0.34* 0.00 0.19* 
EE2.18 0.48* 0.26* 0.56 0.00 0.24* 
EE2.19 0.19* 0.08* 0.14* 0.00 0.12* 
EE2.20 0.22* 0.09* 0.18* 0.00 0.19* 
CE3.12 150 4.14 6.87 37.0 0.00 0.10* 
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EE2.21 0.28* 0.11* 0.33* 0.00 0.30* 
EE2.22 0.18* 0.09* 0.17* 0.00 0.19* 
Table 32. EE3 Pulse Samples. 
Sample Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
EE3.17 0.62 0.15* 0.42* 0.00 0.17* 
EE3.18 0.43* 0.12* 0.39* 0.00 0.14* 
EE3.19 0.50 0.15* 0.46* 0.00 0.16* 
EE3.20 1.59 0.81 0.28* 0.00 0.16* 
EE3.21 1.02 0.55 0.29* 0.00 0.17* 
EE3.22 1.38 0.71 0.33* 0.00 0.20* 
EE3.23 0.35* 0.18* 0.25* 0.00 0.11* 
EE3.24 0.47* 0.19* 0.28* 0.00 0.13* 
EE3.25 0.45* 0.22* 0.27* 0.00 0.13* 
EE3.26 0.73 0.41* 0.47* 0.00 0.13* 
EE3.27 1.37 0.22* 0.45* 0.00 0.36* 
EE3.28 0.65 0.12* 0.32* 0.00 0.18* 
EE3.29 1.26 0.36* 0.57 0.00 0.32* 
EE3.30 0.62 0.49* 0.35* 0.00 0.19* 
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EE3.31 0.25* 0.25* 0.24* 0.00 0.15* 
EE3.32 0.30* 0.26* 0.24* 0.00 0.11* 
EE3.33 0.25* 0.28* 0.24* 0.00 0.10* 
EE3.34 0.19* 0.28* 0.24* 0.00 0.15* 
EE3.35 0.17* 0.27* 0.27* 0.00 0.17* 
EE3.36 0.16* 0.31* 0.29* 0.00 0.14* 
EE3.37 0.18* 0.40* 0.30* 0.00 0.12* 
EE3.38 0.26* 0.56 0.26* 0.00 0.18* 
EE3.39 0.13* 0.43* 0.27* 0.00 0.14* 
EE3.40 0.20* 0.80 0.36* 0.00 0.17* 
Table 33. CE2 Pulse Samples. 
Sample Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
CE2.13 1.26 2.85 5.11 0.00 0.34* 
CE2.14 0.57 1.16 1.84 0.00 0.18* 
CE2.15 0.45* 1.05 1.62 0.00 0.15* 
CE2.16 0.44* 0.87 2.13 0.00 0.15* 
CE2.17 0.54 1.60 1.92 0.00 0.22* 
CE2.18 1.47 3.62 5.01 0.00 0.30* 
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CE2.19 1.28 4.14 4.80 0.00 0.32* 
CE2.20 0.30* 0.67 0.51 0.00 0.15* 
CE2.21 0.32* 0.63 0.69 0.00 0.18* 
CE2.22 0.31* 0.78 0.94 0.00 0.11* 
Table 34. CE3 Pulse Samples. 
Sample Methamphetamine Pseudoephedrine Ephedrine CMP Amphetamine 
CE3.13 4.63 7.59 21.9 0.00 0.27* 
CE3.14 3.21 5.17 17.7 0.00 0.22* 
CE3.15 2.50 4.78 12.7 0.00 0.23* 
CE3.16 2.32 4.18 9.70 0.00 0.25* 
CE3.17 1.68 2.73 5.52 0.00 0.22* 
CE3.18 1.03 1.77 2.96 0.00 0.19* 
CE3.19 2.92 5.06 5.71 0.00 0.37* 
CE3.20 3.34 5.04 5.24 0.00 0.19* 
CE3.21 3.48 5.07 5.32 0.00 0.18* 
CE3.22 1.57 2.54 2.59 0.00 0.30* 
CE3.23 1.18 1.81 2.27 0.00 0.19* 
CE3.24 3.32 1.39 1.89 0.00 0.31* 
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CE3.25 2.01 0.64 0.84 0.00 0.32* 
CE3.26 2.30 0.55 0.79 0.00 0.34* 
CE3.27 2.24 0.61 0.79 0.00 0.36* 
CE3.28 0.71 0.88 0.45* 0.00 0.23* 
In comparing the two solvent types, the highest or maximum concentrations for 
each One Pot methamphetamine waste deposit type, diethyl ether or camp fuel, are listed 
in Table 35 below.  Any result listed below a value of 0.5 ng/mL is outside of the 
calibration range; however, an estimated value was listed if the chromatographic peak 
met identification criteria.  These values are denoted with a single asterisk in the table 
below.  All values are listed in ng/mL.  
Table 35. Average maximum concentrations (ng/mL) observed for methamphetamine, CMP, pseudoephedrine, 
ephedrine, and amphetamine in sewage water samples collected after diethyl ether and camp fuel One Pot waste 
deposits. 
Compound EE Max Conc. CE Max Conc. 
Methamphetamine 6.11 24.50 
CMP 0.55  0.18* 
Pseudoephedrine 2.33 20.53 
Ephedrine 11.32 86.43 
Amphetamine 0.51  0.21* 
Statistical analysis of a two-population t-test, comparing the average maximum 
compound concentrations of EE1-EE3 and CE1-CE3, produced the corresponding results 
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listed below in Table 36.  Calculated p-values demonstrated no significant difference in 
the maximum concentration detected for methamphetamine, but the remaining 
compounds proved to be statistically different.  CMP and amphetamine were not 
statistically compared because the average value of Camp Fuel samples was below the 
LOQ. 
Table 36. Statistical Comparison of Ether and Camp Fuel Effluent Samples.  All values listed in the “EE” and “CE” are 
in ng/mL and represent the average maximal concentration of the corresponding drug detecting in waste water.  A two-
population t-test was performed to compare the mean average concentration of ether and camp fuel for 
methamphetamine, pseudoephedrine, and ephedrine.  A generated p-value less than 0.05 translates to a statistical 
difference between the two solvent types.  A p-value less than 0.01 or less than 0.001, indicate a high statistical 
difference or extreme statistical difference, respectively 
Sewage Effluent (ng/mL) EE CE p-value (two-tailed) 
Methamphetamine 6.11 24.50 0.10   
Pseudoephedrine 2.33 20.53 0.0009*** 
Ephedrine 11.32 86.43 0.002** 
*p-values<0.05 signifying a statistical difference between the concentrations observed 
in the ether cooks and the camp fuel cooks. 
**p-values<0.01 signifying a high statistical difference between the concentrations 
observed in the ether cooks and the camp fuel cooks. 
***p-values<0.001 signifying an extreme statistical difference between the 
concentrations observed in the ether cooks and the camp fuel cooks. 
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For lithium analysis, Table 37 below lists lithium concentration in microgram per 
gram for autosampler bottles 1, 4, and 5 of each deposit.  These bottles were collected at 
time equals -15, 45, and 60 minutes, respectively. 
Table 37. Lithium Concentration from ICP-MS analysis 
Sample Lithium Concentration (µg/g) 
CE 1-1 ND 
CE 1-4 ND 
CE 1-5 0.25 
CE 2-1 ND 
CE 2-4 ND 
CE 2-5 0.30 
CE 3-1 ND 
CE 3-4 0.23 
CE 3-5 0.17 
EE 1-1 ND 
EE 1-4 0.12 
EE 1-5 0.08 
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EE 2-1 0.01 
EE 2-4 ND 
EE 2-5 0.06 
EE 3-1 0.02 
EE 3-4 0.02 
EE 3-5 0.18 
Figure 15-Figure 19 shows graphical representation of the concentration (ng/mL) of 
methamphetamine, pseudoephedrine, ephedrine, CMP, and amphetamine observed in the 
sewage water time course samples collected after the ether One Pot waste deposits.  EE1 
and EE3 followed the same rise-fall pattern, where the highest concentration of each 
drug, except amphetamine, was observed between 45 and 60 minutes.  After this peak, 
the concentration dropped significantly for 30 minutes and then the rate of the decline 
began to lessen over time.  For example, EE2 showed a large increase in all drug 
concentrations, except amphetamine, over the first two hours and then a large decrease in 
all drug concentrations, except amphetamine, over the second two-hour period.  For all 
three ether One Pot waste deposits, amphetamine remained at the same concentration, 
visually, throughout the 3 to 4-hour timeframe. 
93 
 
 
Figure 15. Change in methamphetamine concentration (ng/mL) observed in sewage water samples taken every 15 
minutes after ether cook waste deposits. 
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Figure 16. Change in pseudoephedrine concentration (ng/mL) observed in sewage water samples taken every 15 
minutes after ether cook waste deposits. 
 
Figure 17. Change in ephedrine concentration (ng/mL) observed in sewage water samples taken every 15 minutes after 
ether cook waste deposits. 
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Figure 18. Change in CMP concentration (ng/mL) observed in sewage water samples taken every 15 minutes after 
ether cook waste deposits. 
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Figure 19. Change in amphetamine concentration (ng/mL) observed in sewage water samples taken every 15 minutes 
after ether cook waste deposits. 
Figure 20-Figure 24 show a graphical demonstration of the concentration (ng/mL) of 
methamphetamine, pseudoephedrine, ephedrine, CMP, and amphetamine observed in the 
time course sewage water samples collected after the camp fuel One Pot waste deposits.  
All three camp fuel deposits followed the same rise-fall pattern, where the highest 
concentration of each drug, except amphetamine, was observed between 30 and 60 
minutes.  After this, the concentration dropped significantly for 30 minutes and then the 
rate of decline began to lessen over time.  For all three camp fuel One Pot waste deposits, 
amphetamine remained at the same concentration, visually, throughout the 3 to 4-hour 
timeframe. 
 
Figure 20. Change in methamphetamine concentration (ng/mL) observed in sewage water samples taken every 15 
minutes after camp fuel cook waste deposits. 
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Figure 21. Change in pseudoephedrine concentration (ng/mL) observed in sewage water samples taken every 15 
minutes after camp fuel cook waste deposits. 
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Figure 22. Change in ephedrine concentration (ng/mL) observed in sewage water samples taken every 15 minutes after 
camp fuel cook waste deposits. 
 
Figure 23. Change in CMP concentration (ng/mL) observed in sewage water samples taken every 15 minutes after 
camp fuel cook waste deposits. 
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Figure 24. Change in amphetamine concentration (ng/mL) observed in sewage water samples taken every 15 minutes 
after camp fuel cook waste deposits. 
 Figure 25-Figure 34 are alternating figures. The odd numbered figures show the 
concentration (ng/mL) of methamphetamine, pseudoephedrine, ephedrine, CMP, and 
amphetamine observed in the time course sewage water samples collected after all six 
One Pot waste deposits.  The even numbered figures compare the average concentrations 
(ng/mL) of these compounds observed in sewage water samples after the ether One Pot 
waste deposits to the average concentrations observed in sewage water samples after the 
camp fuel One Pot waste deposits.  Higher methamphetamine, pseudoephedrine, and 
ephedrine concentrations were observed, visually, in sewage water samples collected 
after camp fuel One Pot waste deposits. 
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Figure 25. Comparison of the concentration of methamphetamine (ng/mL) observed in sewage water samples every 15 
minutes for all One Pot waste deposits. 
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Figure 26. Average concentration of methamphetamine (ng/mL) observed every 15 minutes after One Pot waste 
deposits. 
 
Figure 27. Comparison of the concentration of pseudoephedrine (ng/mL) observed in sewage water samples collected 
every 15 minutes for all One Pot waste deposits. 
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Figure 28. Average concentration of pseudoephedrine (ng/mL) observed every 15 minutes after One Pot waste 
deposits. 
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Figure 29. Comparison of the concentration of ephedrine (ng/mL) observed in sewage water samples collected every 
15 minutes for all One Pot waste deposits. 
 
Figure 30. Average concentration of ephedrine (ng/mL) observed every 15 minutes after One Pot waste deposits. 
 
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
0 20 40 60 80 100 120 140 160 180
C
o
n
ce
n
tr
at
io
n
 (
n
g/
m
L)
Time (minutes)
Average Ephedrine Conc. vs. Time
EE (avg)
CE (avg)
104 
 
 
Figure 31. Comparison of the concentration of CMP (ng/mL) observed in sewage water samples collected every 15 
minutes for all One Pot waste deposits. 
 
Figure 32. Average concentration of CMP (ng/mL) observed every 15 minutes after One Pot waste deposits. 
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Figure 33. Comparison of the concentration of amphetamine (ng/mL) observed in sewage water samples collected 
every 15 minutes for all One Pot waste deposits. 
 
Figure 34. Average concentration of amphetamine (ng/mL) observed every 15 minutes after One Pot waste deposits. 
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The final laboratory results pertain the samples obtained from EE4 and CE4 
syntheses.  As mentioned in the methodology section, post-salt solvent, sludge, and 
product salts samples were stored for laboratory analysis, and not to be used within waste 
water deposit experiments.  The characterization results from Chapter 2 provided drug 
compound concentrations within One Pot reaction waste.  However, an additional 
synthesis of each solvent type was conducted to verify the results established in the 
previous chapter.  Upon LC-MS/MS analysis, the following results were observed, as 
listed in Table 38. 
Table 38. Characterization results from EE4 and CE4 reaction waste samples.  All values listed in ng/mL. 
 
Post-Salt Solvent Sludge Product Salt 
Compound EE4 CE4 EE4 CE4 EE4 CE4 
Methamphetamine 102.4 2698 14.52 10.33 32.12 42.56 
CMP 10.17 5.05 0.98 0.34 2.45 0.52 
Pseudoephedrine 7.17 410.9 0.44 1.23 1.38 4.56 
Ephedrine 28.7 1570 3.75 4.16 12.47 26.84 
Amphetamine 0.00 0.00 0.00 0.00 0.00 0.00 
 
The results indicate a much greater presence of drug compounds, with the exception of 
CMP, within the CE4 post-salt solvent than the EE4 post-salt solvent.  As for the sludge 
and product salt samples, the two solvent types produced visually similar results. 
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3.5 Discussion 
Based on the results of the SPE validation, a successful method was developed 
and implemented within OSU-FTTL to detect and quantitate One Pot methamphetamine 
related compounds.  A LOQ was successfully established at 0.5 ng/mL for all target 
compounds.  Accuracy and precision of both the calibrator and quality control levels fell 
within plus or minus 30% of the actual concentration.  The matrix effects study 
demonstrated success with plus or minus 20% calculated values for all compounds.  
Additionally, recovery and process efficiencies were calculated for increased intel 
regarding the extraction process. 
Following method validation, One Pot methamphetamine syntheses, were 
successfully performed.  Overall, eight reactions were conducted, four utilizing diethyl 
ether and four utilizing camp fuel as the reaction solvent.  As described above, the 
simulated laboratory waste solutions that were combined to create the total One Pot waste 
deposit were a lithium-in-water solution, sludge, and a post-salt solvent.  After waste 
water collection, lithium was detectable with ICP-MS analysis.  Based on the samples 
tested for the presence of lithium, a baseline sample, or sample collected prior to deposit, 
was compared with a peak sample, or sample likely to contain the highest abundance of 
the target compound.  The peak samples were determined based on the results of the 
green dye tests, which provided approximate travel times of the One Pot manufacturing 
waste from the deposit site to the sampling location.  According to the results obtained by 
SRNL ICP-MS analysis, lithium was not detected in two thirds of the base line samples.  
The only positive detections were EE2.1 and EE3.1, with concentrations of 0.01 and 0.02 
ug/g, respectively.  On the other hand, every deposit detected lithium in one or both of 
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the peak samples tested.  The highest detected concentration of lithium was 0.30 ug/g, 
while the average of all detections, excluding baseline samples, was 0.16 ug/g.  More 
research will need to be conducted, but based on the ICP-MS results, a spike in lithium 
concentrations within waste water could contribute to the identification of a One Pot 
methamphetamine laboratory. 
Based on the waste water analysis of SPE with LC-MS/MS, methamphetamine, 
pseudoephedrine, ephedrine, CMP, and amphetamine were detected following One Pot 
waste deposit.  As shown in the graph figures above, the time course samples 
demonstrated a low baseline of target compound, a sharp spike or increase, and then 
gradual decrease in concentration.  Continued research is needed to determine if a similar 
spike in One Pot signature compounds and byproducts can be observed in uncontrolled or 
community situations. 
A statistical test was performed on Time Course samples, with this analysis 
comparing EE and CE results of the average maximum concentrations obtained from 
each deposit.  According to the results, every compound, with the exception of 
methamphetamine, was significantly different when comparing the two solvents 
commonly used in the One Pot method.  For pseudoephedrine and ephedrine, a great 
statistical divide was experienced with p-values of 0.009 and 0.002, respectively.  A 
similar argument can be made for methamphetamine, but based solely on visual 
observation of the concentrations obtained.  For these three compounds, concentrations 
within the camp fuel effluent were much higher than those within the diethyl ether 
effluents.  CMP and amphetamine, were not included in the statistical comparison, but 
demonstrated higher concentrations in favor of the diethyl ether deposits.  The LC-
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MS/MS characterization of EE4 and CE4 provides some explanation for the statistical 
differences observed within the two solvent type deposits.  In contrast to the 
characterization results in Chapter 2, with the diethyl ether samples demonstrating a 
higher concentration of target compounds, the results from EE4 and CE4 exhibited the 
opposite.  For the post-salt solvent sample, in particular, methamphetamine, 
pseudoephedrine, and ephedrine were roughly ten times the concentration within the CE4 
sample when compared to the EE4 sample.  Since these two One Pot reactions were 
performed in conjunction with EE1-EE3 and CE1-CE3, a safe assumption is that the 
reactions used for each waste water deposit, contained similar drug concentrations.  The 
identification of the increased concentrations within CE post-salt solvents is a probable 
cause for the statistical difference of the average maximum concentration of 
methamphetamine, pseudoephedrine, and ephedrine observed following waste water 
analysis. 
Additional waste water samples tested using LC-MS/MS analysis included those 
referred to as Pulse samples.  As mentioned above, the Pulse feature on the waste water 
autosampler did not function properly.  A varying number of samples were collected 
following each deposit, if any at all.  For the samples collected at each pumpdown of the 
lift station, methamphetamine, pseudoephedrine, ephedrine, and amphetamine were 
detected at varying concentrations post-deposit.  No noticeable trends were observed in 
the results, as concentrations would increase and decrease sporadically over the course of 
sample collection.  An additional finding is that CMP was not detectable after an 
extended period of time.  Since CMP was not detected in any of the Pulse samples, the 
Time Course samples were examined for the longest detection window of CMP in this 
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study.  For diethyl ether and camp fuel deposits, the largest detection window is 195 and 
150 minutes, respectively.  The true detection window would require an additional test 
with an increased volume of time course samples.  Knowledge that a window of detection 
exists for CMP could potentially be problematic for the implementation of the current 
reported methodology into the law enforcement community. 
An important note based on all the LC-MS/MS waste water results is that the 
volume of sample utilized was only 2 mL, as compared to common sample volumes in 
the literature ranging up to hundreds of milliliters.  With the controlled experimental 
setting and relatively small waste water system, 2 mL of sample was sufficient to detect 
compounds of the One Pot methamphetamine method.  However, continued research, 
specifically increased sample volume extraction, will enhance the detection capabilities.  
For the signature manufacturing byproduct, CMP, improvements in methodology would 
only increase the window of detection for this compound.  Future studies will not only 
need to conduct waste water testing for all target compounds within community settings, 
but confirm, or help to assign, drug concentrations within waste water being attributed to 
the disposal of One Pot methamphetamine waste material.  As of now, the primary 
demand for continuing research lies with the determination of any other possible sources 
of CMP introduction into sewage effluent. 
In summary, a simulated One Pot waste disposal experiment was successful in 
detecting the target compounds of methamphetamine manufacturing, which include, 
methamphetamine, pseudoephedrine, ephedrine, and CMP.  The main metabolite of 
methamphetamine, amphetamine, was included in the detection method as a potential 
indicator of methamphetamine concentrations attributed to human consumption.  Based 
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on the results, collected waste water over time demonstrated a dramatic increase or spike 
in all target compounds of the One Pot method.  Additionally, no similar increase in 
amphetamine was observed.  This successful experiment demonstrates the potential to 
implement waste water analysis as means to track and monitor clandestine laboratories 
within communities.  Further research into this matter will increase detection capabilities, 
assist in assigning the source of the target compounds, and potentially, help locate and 
remove dangerous One Pot methamphetamine laboratories throughout the country.  
Consequently, this removal would also eliminate the likely harm that the hazardous and 
toxic chemicals associated with the One Pot method would cause to innocent bystanders 
and the environment. 
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CHAPTER IV 
 
 
CMP DETECTION IN URINE SAMPLES 
4.1 Introduction 
 1-(1’,4’-cyclohexadienyl)-2-methylaminopropane, or CMP, has been identified as 
a signature byproduct of both the Birch Reduction and One Pot methamphetamine 
manufacturing methods, as explained in Chapter 2.  The results from the second chapter 
confirmed the presence of CMP within One Pot reaction products, as well as waste 
material.  In Chapter 3, the focus was centered around the ability to detect One Pot target 
compounds within waste water as a means to identify the location of clandestine 
laboratories within a community.  Although CMP was detectable in sewage effluent 
following simulated waste disposal, a significant uncertainty exists in regards to whether 
the detection of the byproduct definitively identifies the presence of One Pot reaction 
waste.  If CMP is detectable in trace amounts within the final methamphetamine salt that 
individuals are illicitly using, and potentially abusing, it is possible that CMP would 
excreted from the human body, thus contributing to any concentrations found within 
waste water. 
 One Pot methamphetamine product will potentially contain three compounds: 
methamphetamine, pseudoephedrine, and CMP.  Depending on a variety of 
manufacturing factors, the amount of pseudoephedrine and CMP may be great or small.
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Also, a product salt may have the possibility of not containing any starting material or 
byproduct.  The results from Chapters 2 and 3, demonstrate a fairly large amount of 
pseudoephedrine following a 2-hour reaction.  However, the OSU-FTTL One Pot 
method, as mentioned, is a scaled-down version for safety purposes.  In a clandestine 
setting, an individual may use excess materials to ensure a more quality product.  
Additionally, due to the wide-range of One Pot procedures available online, a multitude 
of yields is likely present within the clandestine laboratory community.  CMP, on the 
other hand, demonstrated higher amounts in One Pot reactions that utilized diethyl ether.  
Camp fuel syntheses, as discussed above, will not produce CMP as readily as diethyl 
ether due to increased immiscibility with water.  Regardless of the amounts of 
pseudoephedrine and CMP within a One Pot product salt, the compounds, in addition to 
methamphetamine, may be consumed with illicit use.  And as a result, knowledge of the 
consumed compounds’ metabolism and excretion characteristics is paramount to any 
waste water analysis designed to detect or locate the presence of One Pot laboratory 
waste. 
As previously discussed, methamphetamine is primarily excreted unchanged, with 
only approximately 10-20% metabolizing into amphetamine.  Pseudoephedrine is 
excreted approximately 70% as the parent compound, and minor amounts are 
metabolized into nor-pseudoephedrine.55  While the pharmacokinetics of starting material 
and the illicit product are well understood, CMP has not been studied within living 
subjects.  The majority of research within the literature pertaining to CMP are focused on 
detection within the environment or clandestine laboratories.  “Chemicals associated with 
clandestine drug laboratories are often disposed of covertly into soil, sewerage systems, 
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or public waste management facilities.”8 Typically, the studies are conducted as a means 
to identify potential pollution within the environment.  While several studies have been 
focused on detecting manufacturing byproducts within soil and monitoring degradation, 
little to no research has been conducted that relate to the last two disposal routes 
mentioned in the quote above.  Human consumption and excretion, as proven with the 
many studies discussed in Chapter 3, have demonstrated drug and metabolite 
contamination of the waste water system.  As a result, any consumed manufacturing 
byproducts would be excreted, providing a detection potential in sewage effluent.  
However, a void in the literature creates uncertainty as to how the primary One Pot 
manufacturing byproduct interacts, i.e. metabolism and excretion patterns, within the 
human body. 
Knowledge of the signature byproduct’s interactions within the body, may not 
only identify other potential compounds to monitor within waste water, but may 
substantiate the significance of a CMP detection.  If CMP is metabolized completely or 
primarily, detection in sewage effluent provides evidence of One Pot methamphetamine 
manufacturing.  CMP metabolism has yet to be fully investigated.  The following study 
was conducted to test urine samples that had previously tested positive for 
methamphetamine.  Anonymized samples were collected from three different sources, 
two being pain management laboratories and another from a medical examiner’s office.  
In total, 47 urine samples were received.  OSU-FTTL, as part of another service, provides 
urine drug testing, therefore each sample received underwent a modified extraction 
process of the validated procedure.  LC-MS/MS analysis provided drug detection results 
for amphetamine, methamphetamine, pseudoephedrine, and CMP only.  Results 
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demonstrate the potential for CMP to be consumed and excreted, as a result of illicit 
methamphetamine use, which has yet to be confirmed in the literature.  However, the 
very low prevalence of CMP within the urine samples indicates that CMP detection in 
waste water may still verify the presence of a One Pot clandestine laboratory. 
4.2 Review of the Literature 
 Since the first discoveries of 1-(1’,4’-cyclohexadienyl)-2-methylaminopropane, 
CMP has been the focal point of several research projects.  As mentioned above, this 
byproduct is signature of methamphetamine manufacturing that utilizes a lithium and 
ammonia reduction.27  The associated clandestine procedures that have been proven to 
result in CMP are the Birch Reduction and One Pot methods.  While the Birch Reduction 
has the potential to produce greater amounts of CMP, the One Pot method, as 
demonstrated in Chapter 2, can have detectable amounts of the byproduct within the final 
methamphetamine salt.  Individuals using an illicit substance produced from either of the 
two manufacturing methods, could potentially be ingesting CMP. 
 Analysis of urine for the presence of drug compounds is not a new endeavor.  
Urine drug testing can be applied to many scenarios, including, but not limited to, 
clinical, research, and forensic settings.  Additionally, urine is typically analyzed to 
ensure individuals within a workplace setting are not abusing drugs that are illegal and/or 
may impair their ability to perform daily tasks.  In fact, in 2003, more than 90% of U.S. 
companies decided to use urine as the specimen to be analyzed for drugs.56  Other bodily 
fluids can be analyzed as well, such as blood or oral fluid, but urine testing is well 
established.  The two primary confirmatory instruments to quantitate drugs within urine 
is GC-MS and LC-MS/MS.  While GC-MS may be the most common, a rise in LC-
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MS/MS prevalence and preference has been documented.57  For the purposes of this 
review, only LC-MS/MS will be discussed as it is the instrument of choice for this study. 
 One of the first uses of LC-MS to analyze illicit drugs in human urine was 
validated in 1996.  Tatsuno et al. developed an LC-MS method due to the challenges 
observed with GC-MS analysis.  The challenges referenced included the demands of 
extensive sample treatment and/or derivatization to detect nonvolatile compounds.58  The 
sample preparation implored for the LC-MS analysis was SPE.  Results indicated 
successful analysis of illicit compounds within urine and demonstrated advantages over 
GC-MS.58  Following initial research determining the possibility and potential of LC-MS, 
many research projects have been conducted to not only improve detection capabilities, 
but also expand the number of compounds that can be detected in a single run.  
According to one report, many groups continued to use traditional GC-MS methodologies 
despite learning of successful implementation of LC-MS.  The reasoning behind this 
“considerable resistance” was not discussed by the authors.60  However, possible sources 
could include immediate and already implemented availability of GC-MS, cost and time 
to acquire and validate LC-MS, and issues with sample interference of closely related 
drug compounds.  Regardless, the discovery of LC-MS/MS, an increase in analytical 
confirmation, and its potential in drug testing became the focal point of many research 
projects, and helped evade the resistance seen with LC-MS.  In 1999, a research group 
utilized LC-MS/MS to analyze several illicit drug compounds in urine samples.  The 
group reported, in describing the instrumentation setup, “a rapid, simple, sensitive LC-
ESI-MS-MS analysis…using specific transitions for each compound of interest.”59  
117 
 
Enhanced sensitivity, with the addition of specific transitions, proved to play an 
important role in the growth of LC-MS/MS analysis prevalence in urine drug testing. 
 With the increasing implementation of LC-MS/MS in the drug testing 
community, many research groups sought to improve detection capabilities, expand the 
number of drugs that could be tested in a single run, and decrease overall analysis time.  
The majority of these goals are not surprising from a business perspective.  LC-MS/MS 
methodologies were developed within laboratories to have the ability to detect many 
numerous drug compounds, both of illicit and pharmaceutical nature.  However, other 
methodologies were developed to focus on the detection of a select group of related 
compounds and/or metabolites.  For instance, Ming-Ren Fuh et al., in 2006, developed a 
method to detect amphetamine and methamphetamine using SPE with LC-MS-MS, and 
successfully reached a detection limit of 1 ng/mL.57  Another group later expanded the 
amphetamine and methamphetamine group to include 3,4-
methylenedioxymethamphetamine or MDMA, and 3,4-methylenedioxyamphetamine or 
MDA.  For these four compounds, Andersson et al. reported LOD values of 43, 8, 8, and 
2 ng/mL, respectively.61  Variable detection limits are pursued depending on the nature of 
the research or business goals.  For instance, a drug testing method designed to analyze 
prescription methamphetamine, Desoxyn, may not necessarily need a low limit of 
detection or quantification, if the goal is to simply confirm or deny an individual’s use of 
the prescription.  On the other hand, if a drug testing method is developed for sewage 
effluent analysis, such as those discussed in Chapter 3, the limit of detection for 
methamphetamine would need to be much lower to detect trace amounts of the illicit 
substance within a vast waste water system. 
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Despite the many varying limits of detection reported for amphetamine and 
methamphetamine, LC-MS/MS analysis of these two compounds within the literature is 
extensive.  For example, method development and LC-MS/MS product design has moved 
beyond the mere detection and quantification of drug compounds.  Several groups have 
conducted studies in regards to enantiomeric separation.  Foster et al., in 1998, developed 
a method to separate, quantitate and compare the presence of d- and l-amphetamine and 
methamphetamine within urine samples.  Results indicated successful separation with an 
ingredient called Marfey’s reagent, and produced limits of detection and quantitation of 
0.16 and 0.40 mg/L, respectively for each enantiomer.62  The successes of this study have 
helped pave the way for research in regards to comparing the amount of illicit versus 
over-the-counter use of methamphetamine.  For instance, a study conducted in 2014 
attempted to separate and quantitate enantiomers to substantiate any claims that a positive 
methamphetamine result was due to use of a nasal decongestant containing the l-
methamphetamine form of the compound.  Newmeyer et al., although not testing urine 
samples, was successful in distinguishing the enantiomer of methamphetamine 
consumed.63  These findings indicate the potential to apply a similar procedure to a 
multitude of samples types such as urine or even waste water. 
Besides methamphetamine and amphetamine, the One Pot manufacturing product 
and metabolite, the precursor pseudoephedrine has also been successfully detected within 
urine.  A recent LC-MS/MS study, conducted in 2015, was able to reach 0.1 ng/mL limit 
of detection for pseudoephedrine, all while analyzing for over 70 other compounds.64  
Other research groups have had similar success.  In fact, the methodology in the 
following section was adopted from an OSU-FTTL method that was developed and is 
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currently being validated to detected a multitude of illicit and pharmaceutical drugs, 
including pseudoephedrine. 
The literature discussed above relates to compounds that will, methamphetamine 
and amphetamine, and may be, pseudoephedrine, detected following the use of One Pot 
methamphetamine product.  However, and as previously mentioned, no research has been 
conducted in regards to detecting CMP, the Birch Reduction and One Pot signature 
byproduct, in urine specimens.  A demand exists for this research to not only potentially 
gather intelligence about the source of the methamphetamine product an individual 
consumed, but also confirm or deny the importance of detecting CMP in waste water as a 
means to identify the presence of a clandestine laboratory.  Until this study, no research 
has been published with regards to CMP’s interaction within the human body.  Further 
and more extensive research is needed to fully understand CMP metabolism and 
potentially identify metabolites that can differentiate methamphetamine consumption 
versus manufacturing waste. 
4.3 Methodology 
Urine samples that had previously tested positive for methamphetamine with LC-
MS/MS were delivered to OSU-FTTL to analyze for the presence of CMP.  The sample 
collection process did not involve interaction with a human subject nor did it provide 
access to identifiable personal and private information.  All urine samples collected were 
completely anonymized.  According to 45 CFR 46.102 (d) and (f) of the Code of Federal 
Regulations for Human Research, this project did not qualify as human subject research 
and was not subject to oversight by the Oklahoma State University Institutional Review 
Board.  Approximately 1 mL of 47 urine samples was delivered to OSU-FTTL, and 
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arrived in tubes labeled as “Urine” with a number designation of 1 through 47.  All 
samples were stored in a freezer until sample preparation and extraction. 
 For laboratory analysis, a different extraction and instrument setup was used when 
compared to the characterization and waste water samples, in Chapters 2 and 3, 
respectively.  A simpler extraction and a different LC-MS/MS platform was utilized 
because of prior and continued success with urine drug testing within OSU-FTTL. 
 LC-MS/MS calibrators and quality controls were prepared using 
methamphetamine, pseudoephedrine, amphetamine, and CMP drug standards mentioned 
previously.  The calibrators included levels of 250, 150, 100, 75, 25, 10, 5, 1, and 0.5 
ng/mL of each compound.  Four QC levels were prepared and included 150, 25, 1, and 
0.1 ng/mL of each compound, and were labeled A, B, C, and D, respectively.  All 
dilutions for the drug levels mentioned above were performed in certified drug-free urine 
(UTAK Laboratories Inc., Valencia, CA).  An un-fortified, drug-free urine sample was 
set aside to be utilized as a negative control.  For an internal standard, a solution was 
prepared using methamphetamine-d5, pseudoephedrine-d3, and amphetamine-d5, all 
purchased from Cerilliant (Cerilliant Corp, Round Rock, TX). 
 For all calibrators, quality controls, and urine sample extractions, 50 L of sample 
was aliquoted into a new tube, alongside 20 L of the prepared Internal Standard 
solution.  Additionally, 180 L of sample diluent, 5% methanol in water, was added to 
each urine sample.  The tube was then capped, vortexed for 10 seconds, and centrifuged 
for 10 minutes at 13,000 revolutions per minute (rpm).  Following centrifugation, 200 L 
of each sample was then transferred to a separate injection vial and stored in a 
refrigerator until LC-MS/MS analysis. 
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Shimadzu UFLC pumps paired with Shimadzu 80-40 MS/MS was used for the 
LC-MS/MS analysis, shown in Figure 35. 
 
Figure 35. LC-MS/MS Instrument Setup at OSU-FTTL.  Shimadzu UFLC pumps on the left and Shimadzu 80-40 
MS/MS on the right. 
For liquid chromatography, separation was achieved with a Restek Raptor Biphenyl 2.7 
µm column (50 x 2.1 mm) with a Restek Raptor Biphenyl 2.7µm guard cartridge (5 x 3.0 
mm) (Restek Corporation, Bellefonte, PA).  Mobile Phase A consisted of 2mM 
ammonium formate and 0.1% formic acid in LC-MS grade water, while Mobile Phase B 
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consisted of 2mM ammonium formate and 0.1% formic acid in LC-MS grade methanol.  
Ammonium formate was purchased from Alfa Aesar (Alfa Aesar, Ward Hill, MA).  
Formic Acid was purchased from EDM (EDM Millipore Corp, Billerica, MA). Methanol 
was purchased from JT Baker (Avantor Performance Materials Inc., Center Valley, PA).  
Nanopure water was obtained using a Barnstead Nanopure Diamond laboratory water 
system (Thermo Scientific, Waltham, MA).  The LC method had a total flow rate of 
0.500 ml/min.  Mobile Phase B concentration began at 5.0% and increased at a consistent 
rate until reaching 95% after 8.5 minutes.  The concentration was then immediately 
increased to 100%, sustained for 45 seconds, immediately decreased back to 5.0%, and 
then held until the conclusion of the sample run at 11 minutes.  Injections were set at 10 
µL and the oven temperature was set to 30 oC. 
For mass spectrometry, two product ions, fragments of the precursor ion, for each 
compound were selected given the mass-to-charge (m/z) ratios that produced optimal 
instrument response, see Table 39. 
Table 39. Mass Spectrometry Parameters.  Target analytes Methamphetamine, Pseudoephedrine, Amphetamine, and 
CMP were identified using two mass ion fragments each.  Internal standards include Methamphetamine-d5, 
Pseudoephedrine-d3, and Amphetamine-d6. 
Compound 
Precursor 
(m/z) 
Product 
(m/z) 
Q1 Pre Bias 
(volts) CE (volts) 
Q3 Pre Bias 
(volts) 
CMP 151.65 58.15 -30.0 -11.0 -21.0 
 
151.65 79.15 -30.0 -18.0 -30.0 
Methamphetamine 149.75 119.05 -16.0 -25.0 -44.0 
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  119.00 91.20 -14.0 -13.0 -33.0 
Methamphetamine-d5 154.95 92.10 -16.0 -20.0 -34.0 
Pseudoephedrine 165.95 148.00 -20.0 -25.0 -14.0 
  165.45 91.00 -46.0 -30.0 -34.0 
Pseudoephedrine-d3 168.9 151.00 -34.0 -14.0 -28.0 
Amphetamine 136.1 91.00 -14.0 -35.0 -32.0 
  135.9 118.95 -16.0 -15.0 -46.0 
Amphetamine-d5 140.9 93.00 -16.0 -17.0 -34.0 
Similar to the other LC-MS/MS analyses, trueness of the compound identity was 
confirmed through comparing the areas of the two MRM transitions, resulting in an 
identification or ID ratio, also known as an MRM ratio.  Every precursor and product ion 
pairing generated a chromatographic peak.  MRM ratios for each compound, with the 
exception of internal standards, were calculated by dividing the peak area of the second 
pairing of each compound by the peak area of the first pairing.  To build an acceptable ID 
ratio range, the ratios observed for every calibrator were averaged.  For results to be 
accepted, the ID ratio must be within 30% of the ID ratio average using two significant 
figures for the percentage value. 
4.4 Findings 
Following the simple extraction of the prepared calibrator and quality control 
samples, LC-MS/MS results indicated accuracy and precision.  Multiple injections of 
each calibrator and quality controls quantitated within plus or minus 30% of the actual 
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concentration.  Additionally, all negative control samples were negative for the target 
compounds.  Based on peak qualifying criteria, listed in the methodology section, the 
following limit of quantitation (LOQ) for amphetamine, methamphetamine, 
pseudoephedrine, and CMP were 5, 75, 5, and 0.5 ng/mL, respectively.  The upper limit 
of quantitation (ULOQ) was 250 ng/mL for all compounds.  The results obtained from 
LC-MS/MS analysis of all 47 urine specimens are listed in Table 40. 
Table 40. LC-MS/MS results of 47 urine samples that previously tested positive for methamphetamine.  The drug 
compounds monitored were amphetamine, methamphetamine, pseudoephedrine, and CMP.  All values listed in the 
table are in ng/mL.  Any positive value above the ULOQ, 250 ng/mL, was reported with a result of >250.  All negative 
values or concentrations that quantitated below the LOQ for each compound, listed in row 2, are designated with five 
hyphen marks. 
  
Amphetamine 
Concentration 
Methamphetamine 
Concentration 
Pseudoephedrine 
Concentration 
CMP 
Concentration 
ULOQ 250 250 250 250 
LOQ 5 75 5 0.5 
Urine 1 >250 >250 ----- ----- 
Urine 2 15.536 135.208 ----- ----- 
Urine 3 152.729 ----- ----- ----- 
Urine 4 210.353 ----- ----- ----- 
Urine 5 >250 >250 ----- ----- 
Urine 6 >250 >250 ----- ----- 
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Urine 7 223.527 >250 ----- ----- 
Urine 8 27.288 >250 ----- ----- 
Urine 9 >250 ----- ----- ----- 
Urine 10 74.819 >250 7.415 1.483 
Urine 11 >250 >250 ----- ----- 
Urine 12 >250 ----- ----- ----- 
Urine 13 >250 ----- ----- ----- 
Urine 14 >250 ----- ----- ----- 
Urine 15 >250 >250 ----- ----- 
Urine 16 49.634 98.975 ----- ----- 
Urine 17 >250 >250 ----- ----- 
Urine 18 >250 >250 ----- ----- 
Urine 19 >250 >250 ----- ----- 
Urine 20 58.801 168.936 ----- ----- 
Urine 21 106.179 >250 ----- ----- 
Urine 22 ----- 121.392 ----- ----- 
Urine 23 >250 >250 ----- ----- 
Urine 24 234.415 >250 ----- ----- 
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Urine 25 179.209 >250 ----- ----- 
Urine 26 >250 >250 ----- ----- 
Urine 27 ----- 204.14 ----- ----- 
Urine 28 >250 >250 ----- ----- 
Urine 29 ----- >250 ----- ----- 
Urine 30 >250 >250 ----- ----- 
Urine 31 >250 >250 ----- ----- 
Urine 32 >250 ----- ----- ----- 
Urine 33 130.768 >250 ----- ----- 
Urine 34 ----- >250 ----- ----- 
Urine 35 >250 >250 ----- ----- 
Urine 36 >250 >250 ----- ----- 
Urine 37 >250 >250 ----- ----- 
Urine 38 >250 >250 ----- ----- 
Urine 39 >250 >250 ----- ----- 
Urine 40 >250 >250 ----- ----- 
Urine 41 >250 >250 ----- ----- 
Urine 42 >250 >250 ----- ----- 
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Urine 43 222.539 >250 ----- ----- 
Urine 44 83.463 >250 ----- ----- 
Urine 45 ----- ----- ----- ----- 
Urine 46 245.182 >250 ----- ----- 
Urine 47 >250 >250 ----- ----- 
 
Only one urine sample, Urine 10, demonstrated positive results for pseudoephedrine and 
CMP.  The majority of the remaining samples tested positive for both methamphetamine 
and amphetamine.  Urine 3-4, 9, 12-14, 32, and 45 tested negative for methamphetamine 
while testing positive for amphetamine.  Urine 22, 27, 29, 34, and 45 tested negative for 
amphetamine while testing positive for methamphetamine.  The only sample to test 
negative for every target compound was Urine 45. 
4.5 Discussion 
 Based on the results above, a relatively low LOQ was achieved for all 
compounds, 5 ng/mL or less, with the exception of methamphetamine.  Two important 
factors negate concern on this matter.  The first is that the LC-MS/MS method was 
slightly modified from a current urine drug testing method of over 70 compounds, that 
had already been validated within OSU-FTTL.  This methodology, in an attempt to avoid 
instrument saturation or over-detection, adjusted several compounds such as 
methamphetamine to not exhibit the optimal response in terms of sensitivity.  As a result, 
methamphetamine is still accurately identified, but large concentrations within a patient 
sample will not overload the instrument detector.  The second reason is that the urine 
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samples received had already been verified to contain methamphetamine.  CMP, the focal 
compound of this study, had the lowest LOQ at 0.5 ng/mL.  As discussed in the chapters 
above, CMP was determined to be present in very small amounts within One Pot 
methamphetamine products.  Therefore, CMP was optimized on the LC-MS/MS to 
generate the best detection results. 
 The analysis of urine samples demonstrated a positive result in every sample, 
except for Urine 45.  This specific sample was the only specimen to observe no peaks for 
any of the target compounds.  A possible explanation for this is that the instruments used 
for the initial and subsequent analyses vary.  While Urine 45 may have tested positive for 
methamphetamine initially, the results did not meet identification criteria on the 
instrumentation at OSU-FTTL.  The majority of samples contained high concentrations 
of both methamphetamine amphetamine, as expected.  Samples delivered to OSU-FTTL 
were previously reported as methamphetamine positive, and as explained above, 
amphetamine is a major metabolite.  All remaining samples tested positive for either 
amphetamine or methamphetamine alone.  However, one sample, Urine 10, demonstrated 
positive results for all four target compounds, amphetamine, methamphetamine, 
pseudoephedrine, and CMP.  The findings within this single sample confirm the 
possibility that CMP can be ingested, as a byproduct of One Pot methamphetamine, and 
then excreted in urine.  This confirmation is the only definitive interpretation of the 
results.  Many unknowns remain unanswered.  Every urine sample, with the exception of 
Urine 10, was negative for both pseudoephedrine and CMP.  Unfortunately, this does not 
eliminate the consumption of One Pot methamphetamine.  With the high variability 
reports in clandestine communities, pseudoephedrine may be completely converted into 
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methamphetamine.  As for CMP, the levels within the consumed methamphetamine salt, 
of unknown origin, may be low enough to avoid detection with the current LOQ of 0.5 
ng/mL.  Additionally, with no prior research or evidence of byproduct’s interaction 
within the body, the results above do not account for any metabolized or degraded CMP 
before excretion.  Perhaps, the methamphetamine consumed in User 10 had significant 
levels of CMP, and thus, could be detected despite compound metabolism. 
 Although several unknowns still exist following this study, a few notions can be 
interpreted from the findings.  CMP has been successful identified in a human urine 
specimen.  While this specific finding, after continued research, may eliminate CMP as 
definitive identifier of a One Pot clandestine laboratory in waste water, the detection does 
provide the law enforcement community with an additional compound to monitor.  The 
presence of CMP within a user’s urine may help indicate or confirm the source of 
methamphetamine manufacturing.  On the other hand, with only a single detection of 
CMP in 47 different urine samples, there lies a possibility that the majority of consumed 
methamphetamine was not produced with the One Pot method.  Further research can 
confirm this notion, but if true, detection of CMP within sewage effluent may still 
uniquely identify the presence of a One Pot methamphetamine laboratory within the 
community. 
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CHAPTER V 
 
 
CONCLUSION 
In summary, the research projects above were designed to characterize and 
develop methodology to proactively detect One Pot clandestine laboratories within the 
population.  The One Pot method has been shown to be the primary manufacturing 
technique over the past decade.  A signature byproduct of the One Pot method was 
previously identified as 1-(1',4'-Cyclohexadienyl)-2-methyl-aminopropane, commonly 
referred to as CMP, and its presence within One Pot methamphetamine products and 
waste materials was confirmed.  To revisit the goals of this study, they included: 
1) characterize the One Pot methamphetamine method,  
2) develop waste water analysis methodologies to detect One Pot waste in 
sewage effluent, and 
3) determine the significance of detecting the primary One Pot byproduct, CMP, 
within environmental samples. 
Based on the findings from the first study in Chapter 2, potential yields found within One 
Pot methamphetamine laboratories were established, and the detectable presence of target 
compounds within reaction waste was discovered and quantified.  CMP, although 
demonstrating greater concentration with diethyl ether reactions, was detectable in both 
final product salts, as well as waste material samples like sludge and post-salt solvent. 
131 
 
The intelligence gathered from these findings will assist future yield and detection studies 
of the One Pot methamphetamine manufacturing method. 
Based on the findings from the second study in Chapter 3, sewage effluent 
samples were collected downstream over time, following a simulated One Pot waste 
disposal into a local waste water system.  As hypothesized, results indicated a significant 
increase or spike in One Pot target compounds.  CMP was determined to have the 
smallest window of detection, but with increased detection capabilities, such as 
increasing sample volume, the byproduct could be detected within sewage effluent for a 
longer period of time following a clandestine laboratory waste disposal.  Additionally, no 
spike in amphetamine, the major metabolite of methamphetamine, was observed.  This 
finding indicates the possibility of monitoring other drug compounds un-related to the 
One Pot method as a means to distinguish methamphetamine consumption versus 
methamphetamine production.  The results from the second study, in general, 
demonstrate the potential to further improve and implement waste water analysis as a 
means to track and locate One Pot clandestine laboratories. 
Based on the results from the third study, CMP can be detected in urine following 
illicit One Pot methamphetamine consumption.  Although a single detection within a 
relatively small sample size cannot provide definitive interpretations, the investigation 
has never been completed and/or documented within the literature.  The findings from the 
analysis of urine samples created a demand and incentive to further study CMP within 
human subjects.  Research projects pertaining to the byproduct’s metabolism and 
excretion patterns, as well as improving analytical detection limits, will help substantiate 
CMP as a unique identifier of clandestine methamphetamine production within 
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environmental samples, and possibly unveil other potential metabolites to monitor during 
waste water analysis. 
 Overall, the results from the three individual, yet related, studies provide both 
previously unknown knowledge and a demand for continued investigation into the One 
Pot methamphetamine method.  One Pot methamphetamine product and reaction waste 
yields have been reported.  Although clandestine laboratory yields can be highly variable, 
the results established the primary compounds of interest that would be important to 
monitor in any detection campaign, whether pertaining to health risks or the environment.  
Additionally, a waste water analysis method was developed and validated to detect the 
target compounds of the One Pot method.  Methodologies from the simulated experiment 
will need to be applied within communities, and detection capabilities increased.  
However, the successful detection of a noticeable and significant increase or spike in 
target compounds post-deposit create the potential to implement waste water analysis in a 
law enforcement setting.  And lastly, urine samples, which had previously tested positive 
for methamphetamine, were analyzed for the presence of the One Pot precursor and 
primary byproduct.  Results demonstrated one sample out of 47 was positive for both 
compounds.  In addition to providing potential information in regards to the source of 
consumed methamphetamine, the findings could potentially indicate that the majority of 
methamphetamine users tested did not consume One Pot methamphetamine.  Depending 
on the trends in the studied community or population, a CMP detection, and most 
certainly a spike, within sewage effluent could indicate the presence of One Pot 
methamphetamine waste. 
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Expanded research of the manufacturing process, produced target compounds and 
byproducts, potential sources of related compounds into the environment, and detection 
capabilities will continue to increase the awareness of the law enforcement and scientific 
communities in regards to the One Pot methamphetamine method.  Due to this method’s 
popularity and reported dangers, clandestine laboratories, from a public safety standpoint, 
need to be identified before the reactions and toxic chemicals cause adverse health effects 
for family members, friends, and neighbors.  And the overall goal of continued research 
is to assist in the investigation and removal of clandestine laboratories from the 
community and environment before more harm is done.  The accomplishments of this 
research provide the initial pathway to the development of a method to proactively detect 
dangerous One Pot methamphetamine clandestine laboratories.
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